<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder - Cipriani, A - 2013 | Cochrane Library</title> <meta content="Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder - Cipriani, A - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003196.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder - Cipriani, A - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003196.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003196.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder" name="citation_title"/> <meta content="Andrea Cipriani" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Keith Reid" name="citation_author"/> <meta content="Northumberland Tyne and Wear NHS Foundation Trust" name="citation_author_institution"/> <meta content="Allan H Young" name="citation_author"/> <meta content="Imperial College London" name="citation_author_institution"/> <meta content="Karine Macritchie" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="John Geddes" name="citation_author"/> <meta content="University of Oxford/Warneford Hospital" name="citation_author_institution"/> <meta content="john.geddes@psych.ox.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD003196.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/10/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003196.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003196.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003196.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antimanic Agents [*therapeutic use]; Benzodiazepines [therapeutic use]; Bipolar Disorder [*drug therapy, prevention &amp; control]; Drug Therapy, Combination [methods]; Lithium Compounds [therapeutic use]; Olanzapine; Randomized Controlled Trials as Topic; Secondary Prevention; Valproic Acid [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003196.pub2&amp;doi=10.1002/14651858.CD003196.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="XwNPMGod";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003196\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003196\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003196.pub2",title:"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder",firstPublishedDate:"Oct 17, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003196.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003196.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003196.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003196.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003196.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003196.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003196.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003196.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003196.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003196.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15593 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003196.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-sec1-0005"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/table_n/CD003196StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/table_n/CD003196StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#CD003196-cr-0002">Andrea Cipriani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#CD003196-cr-0003">Keith Reid</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#CD003196-cr-0004">Allan H Young</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#CD003196-cr-0005">Karine Macritchie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information#CD003196-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>John Geddes</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information/en#CD003196-sec1-0014">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 October 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003196.pub2">https://doi.org/10.1002/14651858.CD003196.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003196-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003196-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003196-abs-0002">Español</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003196-abs-0001" lang="en"> <section id="CD003196-abs1-0001"> <h3 class="title" id="CD003196-abs1-0001">Background</h3> <p>Bipolar disorder is a recurrent illness that is amongst the top 30 causes of disability worldwide and is associated with significant healthcare costs. In the past, emphasis was placed solely on the treatment of acute episodes of bipolar disorder; recently, the importance of episode prevention and of minimisation of iatrogenicity has been recognised. For many years, lithium was the only mood stabiliser in common use, and it remains an agent of first choice in the preventative treatment of bipolar disorder. However, an estimated 20% to 40% of patients may not respond adequately to lithium. Valproate is an anticonvulsant drug that has been shown to be effective in acute mania and is frequently used in maintenance treatment of bipolar disorder. When the acceptability of long‐term treatment is considered, together with efficacy, the adverse event profile of a medication is also important. This is an update of a Cochrane review first published in 2001 and last updated in 2009. </p> </section> <section id="CD003196-abs1-0002"> <h3 class="title" id="CD003196-abs1-0002">Objectives</h3> <p>1. To determine the efficacy of valproate continuation and maintenance treatment:</p> <p>a) in preventing or attenuating manic, depressive and mixed episodes of bipolar disorder;</p> <p>b) in preventing or attenuating episodes of bipolar disorder in patients with rapid cycling disorder; and </p> <p>c) in improving patients' general health and social functioning, as measured by global clinical impression, employment and marital stability. </p> <p>2. To review the acceptability to patients of long‐term valproate treatment, as measured by numbers of dropouts and reasons for dropping out, by compliance and by reference to patients' expressed views regarding treatment. </p> <p>3. To investigate the adverse effects of valproate treatment (including general prevalence of side effects) and overall mortality rates. </p> </section> <section id="CD003196-abs1-0003"> <h3 class="title" id="CD003196-abs1-0003">Search methods</h3> <p>Search of the Cochrane Register of Controlled Trials and the Cochrane Depression, Anxiety and Neurosis Group Register (CCDANCTR) (to January 2013), which includes relevant randomised controlled trials from the following bibliographic databases: The Cochrane Library (all years), EMBASE, (1974 to date), MEDLINE (1950 to date) and PsycINFO (1967 to date). No language restrictions were applied. Reference lists of relevant papers and previous systematic reviews were handsearched. Pharmaceutical companies marketing valproate and experts in this field were contacted for supplemental data. </p> </section> <section id="CD003196-abs1-0004"> <h3 class="title" id="CD003196-abs1-0004">Selection criteria</h3> <p>Randomised controlled trials allocating participants with bipolar disorder to long‐term treatment with valproate or any other mood stabiliser, or antipsychotic drugs, or placebo. Maintenance treatment was defined as treatment instituted specifically or mainly to prevent further episodes of illness. </p> </section> <section id="CD003196-abs1-0005"> <h3 class="title" id="CD003196-abs1-0005">Data collection and analysis</h3> <p>Three review authors independently extracted data. A double‐entry procedure was employed by two review authors. Information extracted included study characteristics, participant characteristics, intervention details and outcome measures in terms of efficacy, acceptability and tolerability. For dichotomous data, risk ratios were calculated with 95% confidence intervals (CIs). For statistically significant results, we calculated the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH). For continuous data, mean differences (MDs) or standardised mean differences (SMDs) were calculated along with 95% CIs. MDs were used when the same scale was used to measure an outcome; SMDs were employed when different scales were used to measure the same outcome. The primary analysis used a fixed‐effect model. Binary outcomes were calculated on a strict intention‐to‐treat (ITT) basis; dropouts were included in this analysis. When data were missing and the method of "last observation carried forward" (LOCF) had been used to do an ITT analysis, then the LOCF data were used. </p> </section> <section id="CD003196-abs1-0006"> <h3 class="title" id="CD003196-abs1-0006">Main results</h3> <p>Six randomised controlled trials (overall 876 participants) lasting 6 to 24 months were included. Two studies (overall 312 participants) compared valproate with placebo, four studies (overall 618 participants) valproate with lithium, one study (overall 23 participants) valproate with olanzapine and one study (overall 220 participants) valproate with the combination of valproate plus lithium. In terms of study quality, most studies reported the methods used to generate random sequence; however, only one study reported enough details on allocation concealment. Four of six included studies described their design as “double blind”, but only two trials reported full details about blinding. Valproate was more effective than placebo in preventing study withdrawal due to any mood episode (RR 0.68, 95% CI 0.49 to 0.93; NNTB 8), but no difference in efficacy was found between valproate and lithium (RR 1.02, 95% CI 0.87 to 1.20). Valproate was associated with fewer participants dropping out of treatment for any cause when compared with placebo or lithium (RR 0.82, 95% CI 0.71 to 0.95 and RR 0.87, 95% CI 0.77 to 0.98, respectively). However, combination therapy with lithium plus valproate was more likely to prevent relapse than was monotherapy with valproate (RR 0.78, 95% CI 0.63 to 0.96). Significant differences in adverse event frequencies were found, and lithium was associated with more frequent diarrhoea, polyuria, increased thirst and enuresis, whereas valproate was associated with increased sedation and infection. </p> </section> <section id="CD003196-abs1-0007"> <h3 class="title" id="CD003196-abs1-0007">Authors' conclusions</h3> <p>Limited evidence supports the efficacy of valproate in the long‐term treatment of bipolar disorder. Clinicians and patients should consider acceptability and tolerability profile when choosing between lithium and valproate—their combination or other agents—as long‐term treatment for bipolar disorder. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003196-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003196-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003196-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003196-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003196-abs-0003" lang="en"> <h3>Valproate for keeping people with bipolar disorder well, after mood episodes</h3> <p>Bipolar disorder is a common and important disorder that includes episodes of depression, mixed states or mania. Depression includes low mood and energy, as well as lack of enjoyment, often combined with other problems such as sleep disturbance. Mania includes the opposite, with 'too much' energy and problems with high mood or irritation. In mixed states, the symptoms of depression and mania are combined. These mood episodes usually happen several times in an individual's life, so long‐term treatment (maintenance treatment) can be very important in preventing relapse and recurrence. As valproate is a drug that may be useful in treating the acute phase of bipolar disorder, in this review we wanted to answer the following question: Is valproate useful as maintenance treatment for bipolar disorder? </p> <p>We searched, in a wide‐ranging way, for all the useful studies (randomised controlled trials, or RCTs) we could find on long‐term treatment of people with bipolar disorder using valproate or any other mood stabiliser, or antipsychotic drugs, or placebo. Three of us looked at RCTs to make sure they were fair experiments. We extracted data from the studies, put all of the evidence together and carried out a statistical analysis to look for significant results. </p> <p>We conducted these searches to 11 January 2013 and found six studies, including a total of 876 participants. The quality of the studies in terms of design was not good, which means that the effects of some drugs might have been overestimated. All of the trials taken together suggest that valproate might help to prevent relapse in bipolar disorder, especially depressive episodes. However, because of limited available evidence, conclusions on valproate compared with placebo and lithium (or other active drugs) cannot be made with any reliable degree of confidence. Lithium is an important drug to compare with valproate because lithium is already known to be effective in preventing relapses of bipolar disorder. When we combined the findings of all studies comparing valproate with lithium, the evidence did not favour valproate or lithium in terms of efficacy. People taking valproate over a long time were more likely than patients given lithium to keep taking their allocated medication. Clinicians and patients should consider the side effects of valproate, including alopecia, tremor and weight gain. </p> <p>We also found a study that compared valproate taken alone with valproate combination therapy (two drugs taken at the same time). This study compared people who took lithium only or valproate only with people who took valproate and lithium together. No evidence showed that use of valproate and lithium compared with lithium alone helped to ensure that patients kept taking their allocated medication. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003196-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003196-sec1-0006"></div> <h3 class="title" id="CD003196-sec1-0007">Implications for practice</h3> <section id="CD003196-sec1-0007"> <p>A key clinical question is whether valproate or lithium should be favoured as the first‐line therapy in the prevention of recurrence in bipolar disorder. Given the lack of clear findings of this review and the limited amount of evidence obtained, conclusions on the efficacy and acceptability of valproate compared with placebo and lithium cannot be made with any degree of confidence. The evidence of efficacy for valproate versus placebo (in terms of both total participants randomised and independently replicated results) is less robust when compared with the more substantial evidence for the efficacy of lithium versus placebo (<a href="./references#CD003196-bbs2-0021" title="BurgessS , GeddesJ , HawtonK , TownsendE , JamisonK , GoodwinG . Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>). Clinicians should always individualise the best maintenance drug treatment for each patient, in accordance with the efficacy and tolerability of long‐term treatments of documented efficacy. However, in making such clinical decisions, clinicians and patients may wish to consider evidence from a related review that highlights other important factors. These may include differences in the efficacy of drugs in acute treatment of mania (<a href="./references#CD003196-bbs2-0030" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple‐treatments meta‐analysis. Lancet2011;378(9799):1306‐15. ">Cipriani 2011</a>) and the relative acceptability and tolerability of valproate and lithium. In terms of safety, lithium and valproate had different side effect profiles. Our analysis suggests that valproate may be better tolerated than lithium, but comparatively high lithium levels were used in the trial, and it has been shown that informed management of lithium plasma levels may ensure both improved utility and improved outcomes (<a href="./references#CD003196-bbs2-0050" title="MalhiGS , TaniousM , DasP , BerkM . The science and practice of lithium therapy. Australian and New Zealand Journal of Psychiatry2012;46(3):192‐211. ">Mahli 2012</a>). Moreover, a combination therapy with lithium plus valproate may be an option if the patient can tolerate the combination; however, this suggestion is based on evidence from a single study. </p> </section> <h3 class="title" id="CD003196-sec1-0008">Implications for research</h3> <section id="CD003196-sec1-0008"> <p>Longer‐term and larger sample size RCTs, with clinically appropriate designs, are needed, preferentially conducted independent of the manufacturer, to examine the relative efficacy and acceptability of valproate in the maintenance treatment of bipolar disorder. The review of lithium in maintenance therapy concluded that, although the total number of participants randomly assigned was rather small, reasonable evidence for the efficacy of lithium was found (<a href="./references#CD003196-bbs2-0021" title="BurgessS , GeddesJ , HawtonK , TownsendE , JamisonK , GoodwinG . Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>). We would therefore argue that it is unnecessary for future studies to include a placebo arm: The ethical and practical costs of doing so outweigh the possible benefits. Future trials need to compare valproate with other mood‐stabilising agents that have not been compared with valproate so far (e.g. carbamazepine, atypical antipsychotics) and must be of sufficient duration to inform real‐life clinical decision making. Good‐quality trials of valproate are needed: Analysis should be conducted on an intention‐to‐treat basis, and power calculations should be undertaken by using realistic estimates of recurrence rates. Trial outcomes should include measures that are meaningful to patients and clinicians, and recorded side effects should reflect the concerns of patients. Finally, although it is unclear whether valproate exhibits discontinuation effects similar to those exhibited by lithium, trial design should avoid rapid discontinuation of any mood stabiliser. </p> <p>Even though two of the included studies focused on rapid cycling disorder, they were very small, and there remains a need for additional evidence on the use of valproate in such populations of patients. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003196-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003196-sec1-0001"></div> <section id="CD003196-sec2-0001"> <h3 class="title" id="CD003196-sec2-0001">Description of the condition</h3> <p>Bipolar disorder (or bipolar affective disorder, or manic depressive disorder) refers to a group of affective disorders that together are characterised by marked mood swings between mania (mood elevation) and depression that cause significant personal distress or social dysfunction, and are not caused by drugs or known physical disorders (<a href="./references#CD003196-bbs2-0061" title="PhillipsML , KupferDJ . Bipolar disorder diagnosis: challenges and future directions. Lancet2013;381(9878):1663‐71. ">Phillips 2013</a>). Bipolar type I disorder is diagnosed when episodes of depression are interspersed with mania. Bipolar type II disorder is diagnosed when depression is interspersed with less severe episodes of elevated mood (hypomania) that do not lead to dysfunction or disability (<a href="./references#CD003196-bbs2-0054" title="Müller‐OerlinghausenB , BerghöferA , BauerM . Bipolar disorder. Lancet2002;359:241–7. ">Müller‐Oerlinghausen 2002</a>). Lifetime prevalence rates of bipolar type I disorder range from 0.3% to 1.5% in the general population (<a href="./references#CD003196-bbs2-0070" title="WeissmanMM , BlandRC , CaninoGJ . Cross‐national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association1996;276:293–9. ">Weissmann 1996</a>). Men and women are at similar risk, and mean age at first onset ranges from 19 to 29 years (an average of six years earlier than first onset of major depression). The cause of bipolar disorder is uncertain, although family and twin studies suggest a genetic basis (<a href="./references#CD003196-bbs2-0032" title="CraddockN , SklarP . Genetics of bipolar disorder. Lancet2013;381(9878):1654‐62. ">Craddock 2013</a>). Bipolar disorder is a recurrent illness in which affective episodes of varying form may produce lasting destructive effects on sufferers' psychological, professional and social welfare (<a href="./references#CD003196-bbs2-0040" title="Gonzalez‐PintoAM , DardennesR , deZélicourtM , LópezP , OliverosRG , VietaE , et al. In‐patient care costs of patients with bipolar I disorder: a comparison between two European centers. Journal of Affective Disorders2010;121(1‐2):152‐5. [PUBMED: 19482360] ">Gonzalez‐Pinto 2010</a>). Its chronic and recurrent nature places it amongst the top 30 causes of disability worldwide, especially in the age group of 15 to 44 years (<a href="./references#CD003196-bbs2-0053" title="MurrayCJ , LopezAD . Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet1997;349:1436‐42. ">Murray 1997</a>). A meta‐analysis undertaken to compare observed versus expected rates of suicide in an age‐ and sex‐matched sample of the general population found that the lifetime prevalence of suicide in people with bipolar disorder was about 2%—about 15 times greater than would be expected (<a href="./references#CD003196-bbs2-0042" title="HarrisEC , BarracloughB . Suicide as an outcome for mental disorders: a meta‐analysis. British Journal of Psychiatry1997;170:205–8. ">Harris 1997</a>). </p> </section> <section id="CD003196-sec2-0002"> <h3 class="title" id="CD003196-sec2-0002">Description of the intervention</h3> <p>‘Mood stabilisers’ are defined as drugs that alleviate the frequency and/or intensity of manic, depressive or mixed episodes in patients with bipolar disorder and, further, do not increase the frequency or severity of any of the subtypes or course variables of bipolar disorder (<a href="./references#CD003196-bbs2-0020" title="BowdenCL . Role of newer medications for bipolar disorder. Journal of Clinical Psychopharmacology1996;16(Suppl 1):48‐55. ">Bowden 1996</a>). For many years, lithium was the only mood stabiliser in common use, and it remains a first choice in the preventative treatment of bipolar disorder (<a href="./references#CD003196-bbs2-0017" title="American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry1994;151(12 Suppl):1‐36. ">APA 1994b</a>; <a href="./references#CD003196-bbs2-0022" title="YathamLN , KennedySH , SchafferA , ParikhSV , BeaulieuS , O'DonovanC , et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD): collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders2009;11(3):225‐55. [PUBMED: 19419382] ">CANMAT 2009</a>; <a href="./references#CD003196-bbs2-0041" title="GoodwinGM , Consensus Group of the British Association for Psychopharmacology. Evidence‐based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2009;23(4):346‐88. ">Goodwin 2009</a>; <a href="./references#CD003196-bbs2-0038" title="GeddesJR , MiklowitzDJ . Treatment of bipolar disorder. Lancet2013;381(9878):1672‐82. ">Geddes 2013</a>). However, an estimated 20% to 40% of patients may not respond adequately to lithium. In particular, a high incidence of inadequate response has been noted in individuals with rapid cycling disorder (<a href="./references#CD003196-bbs2-0062" title="PostRM . Emerging perspectives on valproate in affective disorders. Journal of Clinical Psychiatry1989;50(Suppl):3‐9. ">Post 1989</a>), a variant of bipolar disorder associated with greater morbidity and mortality than its classic form, including greater risk of suicide (<a href="./references#CD003196-bbs2-0035" title="FawcettJ , SchefterW , FoggL , ClarkDC , YoungMA , HedekerD , et al. Time‐related predictors of suicide in major affective disorder. American Journal of Psychiatry1990;147:1189‐94. ">Fawcett 1990</a>). A search for adjunctive and alternative treatments to lithium has uncovered evidence that other medications, including anticonvulsant agents (e.g. valproic acid, carbamazepine) and several atypical antipsychotics, have mood‐stabilising properties. Valproic acid (together with sodium valproate or valproate sodium, either of which is a sodium salt of valproic acid) is an anticonvulsant that is used also in neurology for the treatment of patients with epilepsy and migraine; in Europe it has been used since 1966 as maintenance treatment for bipolar disorder (<a href="./references#CD003196-bbs2-0049" title="LambertPA , CarrazG , BorselliS , CarrelS . Neuropsychotropic action of a new antiepileptic: depramide [Action neuropsychotrope d'un novel anitepileptique: le Depamide]. Annales Medico‐Psychologiques1966;1(5):707‐10. ">Lambert 1966</a>). </p> </section> <section id="CD003196-sec2-0003"> <h3 class="title" id="CD003196-sec2-0003">How the intervention might work</h3> <p>Valproic acid and its derivatives, hereafter given the generic term 'valproate', are weak blockers of sodium ion channels that produce a weak inhibitor of enzymes that deactivate gamma‐aminobutyric acid (GABA) (such as GABA transaminase) (<a href="./references#CD003196-bbs2-0034" title="FawcettJ . Valproate use in acute mania and bipolar disorder: an international perspective. Journal of Clinical Psychiatry1989;50(3 Suppl):10‐2. ">Fawcett 1989</a>). The exact mechanisms that contribute to the efficacy of valproate in treating bipolar disorder remain unclear. However, it seems unlikely that GABAergic transmission is related to the psychotropic action of valproate, as other different molecular mechanisms might be involved, such as serotonergic and glutamatergic transmission, energy metabolism and neuronal membrane lipid synthesis (<a href="./references#CD003196-bbs2-0071" title="WintererG , HerrmannWM . Valproate and the symptomatic treatment of schizophrenia spectrum patients. Pharmacopsychiatry2000;33:182–8. ">Winterer 2000</a>). Recently, amongst other potential mechanisms of action, neurotrophic and neuroplastic effects of valproate have been explored (<a href="./references#CD003196-bbs2-0064" title="SchloesserRJ , HuangJ , KleinPS , ManjiHK . Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology2008;33(1):110‐33. ">Schloesser 2008</a>). Valproate has a complex pharmacokinetic profile that follows a three‐compartment model and shows protein‐binding saturation. Monitoring of plasma level is supposedly, therefore, of more limited use than with carbamazepine or lithium. A dose of at least 750 mg/d or a serum level of at least 50 mg/L may be associated with response (<a href="./references#CD003196-bbs2-0068" title="TaylorD , DuncanD . Doses of carbamazepine and valproate in bipolar affective disorder. Psychiatric Bulletin1997;21:221‐3. ">Taylor 1997</a>). The therapeutic dose usually ranges between 1000 and 1500 mg/d but can reach a maximum of 2000 mg/d. Valproate is highly protein bound (up to 94%). Other drugs that are highly protein bound can displace valproate from albumin and precipitate toxicity (e.g. aspirin). Valproate is hepatically metabolised and can increase the plasma levels of some drugs, possibly by inhibiting their metabolism (e.g. tricyclic antidepressants, lamotrigine). </p> </section> <section id="CD003196-sec2-0004"> <h3 class="title" id="CD003196-sec2-0004">Why it is important to do this review</h3> <p>Until the recent millennium, valproate was recommended as a second‐line prophylactic agent in bipolar disorder and a first‐line choice in rapid cycling disorder in the United States of America and in Great Britain (<a href="./references#CD003196-bbs2-0017" title="American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry1994;151(12 Suppl):1‐36. ">APA 1994b</a>; <a href="./references#CD003196-bbs2-0063" title="SachsGS . Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. Journal of Clinical Psychopharmacology1996;16(2):32‐46. ">Sachs 1996</a>; <a href="./references#CD003196-bbs2-0051" title="TaylorD , McConnellD , McConnellH , KerwinR . Prescribing guidelines. The South London and Maudsley NHS Trust. 6th Edition. London: Martin Dunitz, 2001. ">Maudsley 2001</a>). Notwithstanding its sometimes troublesome side effect profile, valproate is still frequently used in clinical practice (<a href="./references#CD003196-bbs2-0038" title="GeddesJR , MiklowitzDJ . Treatment of bipolar disorder. Lancet2013;381(9878):1672‐82. ">Geddes 2013</a>). Side effects of valproate include neurological symptoms such as tremor, sedation and ataxia (especially with concomitant administration of other anticonvulsants or neuroleptics), alopecia, lethargy, dizziness, haematological dysfunction, hepatic failure and other gastrointestinal complaints. Asymptomatic elevation in hepatic transaminases may occur. Pancreatitis and hepatotoxicity are rare but potentially serious and fatal complications. Possible induction of polycystic ovaries and hyperandrogenism with long‐term valproate treatment has been reported, especially in young females (<a href="./references#CD003196-bbs2-0037" title="GarlandEJ , BehrR . Hormonal effects of valproic acid?. Journal of the American Academy of Child and Adolescent Psychiatry1996;35(11):1424‐5. ">Garland 1996</a>; <a href="./references#CD003196-bbs2-0039" title="GellerB . Valproate and polycystic ovaries. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:9‐10. ">Geller 1998</a>). Teratogenicity has been reported in the form of neural tube defects associated with first trimester use (<a href="./references#CD003196-bbs2-0047" title="JeavonsPM . Sodium valproate and neural tube defects. Lancet1982;2(8310):1282‐3. ">Jeavons 1982</a>), congenital heart lesions, digital anomalies, oral clefts and craniofacial dysmorphic features (<a href="./references#CD003196-bbs2-0033" title="DukesMN . Anti‐convulsants. Meyler's Side Effects of Drugs: An Encyclopaedia of Adverse Reactions and Interactions. 13th Edition. Amsterdam: Elsevier, 1996. ">Dukes 1996</a>). It has also been found that the use of valproate in pregnancy was associated with a reduction in cognitive functioning in the children of mothers with epilepsy (<a href="./references#CD003196-bbs2-0014" title="AdabN , KiniU , VintenJ , AyresJ , BakerG , Clayton‐SmithJ , et al. The longer term outcome of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery &amp; Psychiatry2004;75(11):1575‐83. ">Adab 2004a</a>; <a href="./references#CD003196-bbs2-0015" title="AdabN , TudurSC , VintenJ , WilliamsonP , WinterbottomJ . Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD004848] ">Adab 2004b</a>; <a href="./references#CD003196-bbs2-0052" title="MeadorKJ , BakerGA , BrowningN , Clayton‐SmithJ , Combs‐CantrellDT , CohenM , et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine2009;360(16):1597‐605. ">Meador 2009</a>). Concerns regarding teratogenicity led to the recommendation by the United Kingdom National Institute of Clinical Excellence (NICE) that valproate should not be prescribed routinely for women of child‐bearing potential (<a href="./references#CD003196-bbs2-0056" title="National Institute of Health and Clinical Excellence (NICE). The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline Number 38. NICE Guidelines2006. ">NICE 2006</a>). Over the past decade, the range of agents available for the maintenance treatment of bipolar disorder has expanded, and new efficacy and safety data on the use of valproate have become available. This is an update of a Cochrane review first published in 2001 and last updated in 2009 (<a href="./references#CD003196-bbs2-0072" title="MacritchieK , GeddesJ , ScottJ , HaslamDR , GoodwinG . Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003196] ">Macritchie 2009</a>). In light of recent developments, this re‐appraisal of valproate in the maintenance treatment of bipolar disorder is due and timely. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003196-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003196-sec1-0002"></div> <p> <ol id="CD003196-lst1-0001"> <li> <p>To determine the efficacy of valproate continuation and maintenance treatment:</p> <ol id="CD003196-lst2-0001"> <li> <p>in preventing or attenuating manic, depressive and mixed episodes of bipolar disorder;</p> </li> <li> <p>in preventing or attenuating episodes of bipolar disorder in patients with rapid cycling disorder; and </p> </li> <li> <p>in improving patients' general health and social functioning, as measured by global clinical impression, employment and marital stability. </p> </li> </ol> </li> <li> <p>To review the acceptability to patients of long‐term valproate treatment, as measured by numbers of dropouts and reasons for dropping out, by compliance and by reference to patients' expressed views regarding treatment. </p> </li> <li> <p>To investigate the adverse effects of valproate treatment (including general prevalence of side effects) and overall mortality rates. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003196-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003196-sec1-0003"></div> <section id="CD003196-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003196-sec3-0001"> <h4 class="title">Types of studies</h4> <p>Prospective randomised controlled trials (RCTs) comparing valproate maintenance treatment with placebo or alternative drug treatment in bipolar disorder were included in this review. Maintenance treatment was defined as treatment instituted specifically or mainly to prevent further episodes of illness. When trials combined acute treatment and maintenance phases, these data would be analysed separately when possible for the purposes of this review. </p> </section> <section id="CD003196-sec3-0002"> <h4 class="title">Types of participants</h4> <p>The review included participants of both sexes with a primary diagnosis of bipolar disorder corresponding to the <i>International Classification of Diseases (ICD), Tenth Revision (ICD‐10),</i> code F31, and the <i>Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition (DSM‐IV)</i> code 296 (trials with <i>ICD, Ninth Revision (ICD‐9)</i> and <i>DSM, Third Edition (DSM‐III)/DSM, Third Edition, Revised (DSM‐III‐R)</i> diagnoses approximating these codes were included). All subtypes of bipolar disorder (rapid cycling [suffering from four or more affective episodes per year] and types I, II and not otherwise specified) were included. </p> <p>No age restrictions were applied.</p> <p>When trials involved heterogenous groups of participants, in particular, those with schizoaffective disorder and recurrent unipolar depression (diagnoses approximating <i>ICD‐10</i> code F25 and <i>DSM‐IV</i> code 295.70; and <i>ICD‐10</i> code F33 and <i>DSM‐IV</i> 296.3, respectively), data were separated into diagnostic groups if randomisation had been stratified. </p> <p>No restrictions on setting were applied.</p> <p>Excluded were studies with participants who had a concurrent primary diagnosis of an Axis I or II disorder and participants with a serious concomitant medical illness. Participants with cyclothymia were excluded as well. </p> </section> <section id="CD003196-sec3-0003"> <h4 class="title">Types of interventions</h4> <section id="CD003196-sec4-0001"> <h5 class="title">Experimental intervention</h5> <p>This intervention consisted of valproate given as monotherapy or in combination with other mood stabilisers. Several formulations of valproate and valproic acid are available, including sodium valproate, valpromide and divalproex. In this review, we refer to these generically as valproate, as this is the term in common usage. However, the precise preparation used in each study was specified (see <a href="./references#CD003196-sec2-0018" title="">Characteristics of included studies</a>), and if heterogeneity was observed, difference in preparation was considered as a potential explanation. </p> </section> <section id="CD003196-sec4-0002"> <h5 class="title">Comparator intervention</h5> <p> <ul id="CD003196-lst1-0002"> <li> <p>Placebo</p> </li> <li> <p>Alternative mood stabiliser (i.e. lithium, carbamazepine)</p> </li> <li> <p>Other treatments (e.g. antipsychotics)</p> </li> </ul> </p> <p>See <a href="#CD003196-sec3-0008">Data extraction and management</a> below for a list of main comparisons. </p> </section> </section> <section id="CD003196-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD003196-sec4-0003"> <h5 class="title">Primary outcomes</h5> <p><b>1. Efficacy of valproate in preventing/attenuating further episodes of affective disorder</b> </p> <p>1.1 Recurrence of any mood episodes, as measured by:</p> <p> <ul id="CD003196-lst1-0003"> <li> <p>study withdrawal due to recurrence of any mood episode;</p> </li> <li> <p>admission to hospital: (i) time to next admission; (ii) number of admissions during trial period; </p> </li> <li> <p>institution of additional treatment for affective episode and time to institution; and </p> </li> <li> <p>number of episodes during the trial period.</p> </li> </ul> </p> <p>We also performed the same analysis for recurrence of manic, mixed or depressive episodes only, if possible. </p> </section> <section id="CD003196-sec4-0004"> <h5 class="title">Secondary outcomes</h5> <p><b>2. Acceptability of treatments</b> </p> <p>2.1 Participants dropping out of treatment during the study period.</p> <p>2.2 Measures of compliance: Completion of the trial was taken as a specific surrogate marker of acceptability. </p> <p>2.3 Participant reports of satisfaction or otherwise with treatment.</p> <p><b>3. Adverse effects</b> </p> <p>3.1 Numbers of participants experiencing the following.</p> <p> <ul id="CD003196-lst1-0004"> <li> <p>Troublesome side effects.</p> </li> <li> <p>Gastrointestinal side effects: anorexia, nausea, vomiting, dyspepsia, diarrhoea.</p> </li> <li> <p>Neurological complaints: tremor, sedation, ataxia, cognitive impairment.</p> </li> <li> <p>Dizziness.</p> </li> <li> <p>Alopecia.</p> </li> <li> <p>Lethargy.</p> </li> <li> <p>Haematological dysfunction.</p> </li> <li> <p>Pancreatitis.</p> </li> <li> <p>Evidence of hepatic dysfunction and hepatotoxicity.</p> </li> <li> <p>Weight gain.</p> </li> <li> <p>Menstrual irregularity, polycystic ovaries and hyperandrogenism.</p> </li> </ul> </p> <p>3.2 Cases of teratogenicity.</p> <p><b>4. General Health and Social Functioning</b> </p> <p>4.1 Clinical global impression of the clinician (Global Assessment of Functioning—GAF) (<a href="./references#CD003196-bbs2-0018" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision. Washington, DC: Author, 2000. ">APA 2000</a>). </p> <p>4.2 Quality of life according to the EuroQol (EQ‐5D) questionnaire (<a href="./references#CD003196-bbs2-0048" title="KindP . The EuroQol instrument: an index of health related quality of life. Spilker B (ed). Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd Edition. Philadelphia: Lippincott‐Raven Publishers, 1996:191‐201. ">Kind 1996</a>). </p> <p>4.3 Employment during study period.</p> <p>4.4 Separation/divorce during study period.</p> <p><b>5. Mortality rates and deliberate self‐harm</b> </p> <p>5.1 Overall mortality rates during study period.</p> <p>5.2 Mortality excluding suicide and verdicts of undetermined death.</p> <p>5.3 Mortality due to hepatic failure.</p> <p>5.4 Mortality due to pancreatitis.</p> <p>5.5 Suicide and verdicts of undetermined death.</p> <p>5.6 Rates of deliberate self‐harm.</p> </section> </section> </section> <section id="CD003196-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003196-sec3-0005"> <h4 class="title">Electronic searches</h4> <section id="CD003196-sec4-0005"> <h5 class="title">CCDAN's specialised register (CCDANCTR)</h5> <p>The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) maintains two clinical trials registers at its editorial base in Bristol, UK: a references register and a studies‐based register. The CCDANCTR‐References Register contains more than 31,500 reports of randomised controlled trials in depression, anxiety and neurosis. Approximately 65% of these references have been tagged to individual, coded trials. The coded trials are held in the CCDANCTR‐Studies Register, and records are linked between the two registers through the use of unique study ID tags. Coding of trials is based on the EU‐Psi coding manual. Please contact the CCDAN Trials Search Co‐ordinator for further details. </p> <p>Reports of trials for inclusion in the Group's registers are collated from routine (weekly), generic searches of MEDLINE (1950 to date), EMBASE (1974 to date) and PsycINFO (1967 to date); quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and review‐specific searches of additional databases. Reports of trials are also sourced from international trials registers c/o the World Health Organization’s trials portal (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>), drug companies, and handsearching of key journals, conference proceedings and other (non‐Cochrane) systematic reviews and meta‐analyses. Details of <a href="http://ccdan.cochrane.org/search-strategies-identification-studies" target="_blank">CCDAN's generic search strategies</a> can be found at the Group's website. </p> <p>The CCDANCTR‐Studies Register was searched using the following terms:<br/> <i>Condition=(bipolar or mani* or schizoaffective) and Intervention=(divalproex or valpro*)</i> </p> <p>The CCDANCTR‐References Register was searched using a more sensitive set of free‐text terms to find additional untagged/uncoded references:<br/> <i>(valpro* or divalpro*) and (bipolar or mania or manic or hypomani* or psychos* or psychotic or postpsycho* or post‐psycho* or "rapid cycling" or schizoaffective)</i> </p> <p>The CCDANCTR was searched (all years to 11 January 2013).</p> <p>Review authors conducted their own searches on EMBASE, MEDLINE, PsycLit and Psyndex to May 2012. </p> </section> <section id="CD003196-sec4-0006"> <h5 class="title">International trial registries</h5> <p>The WHO Clinical trials Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) and <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> were searched (January 2013) to identify additional ongoing or unpublished studies. Clinicalstudyresults.org was also searched (to May 2011). This database no longer exists. </p> </section> <section id="CD003196-sec4-0007"> <h5 class="title">Regulatory agencies</h5> <p>Trial databases of the following drug‐approving agencies were searched for published, unpublished and ongoing controlled trials: the Food and Drug Administration (FDA) in the USA, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the European Medicines Agency (EMA) in the EU. We also searched ongoing trial registers such as International Standard Randomised Controlled Trial Number Register (ISRCTN) and the National Research Register in the UK, Nederland's Trial Register in the Netherlands and European Union Drug Regulating Authorities Clinical Trials (EudraCT) in the EU. These searches were undertaken in February 2012. </p> </section> </section> <section id="CD003196-sec3-0006"> <h4 class="title">Searching other resources</h4> <section id="CD003196-sec4-0008"> <h5 class="title">Personal communication</h5> <p>The contact authors of all review papers or trials over the relevant search period were identified from authorship lists. They and other experts in the field were contacted and asked about their knowledge of other studies, published or unpublished, relevant to the review. Pharmaceutical companies marketing valproate products were requested to provide relevant published and unpublished data. </p> </section> <section id="CD003196-sec4-0009"> <h5 class="title">Reference checking</h5> <p>The reference lists of all reviews, identified RCTs, other relevant papers and major English textbooks on mood disorder were checked for published reports and citations of unpublished research. </p> </section> </section> </section> <section id="CD003196-sec2-0007"> <h3 class="title" id="CD003196-sec2-0007">Data collection and analysis</h3> <section id="CD003196-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Two independent review authors checked to ensure that studies related to valproate generated by the search strategies of the CCDANCTR References and other complementary searches met the inclusion criteria, first based on the title and abstracts. All studies that were rated as possible candidates by either of the two review authors were added to the preliminary list, and their full texts were retrieved. AC and KM then assessed all of the full text articles in this preliminary list to see whether they met the strict inclusion criteria. If the raters disagreed, the final rating was made by consensus, with the involvement, if necessary, of another member of the review group (JG or AHY). </p> </section> <section id="CD003196-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>AC and KM extracted data from the included studies. Any disagreement was discussed, and decisions were documented. If necessary, we contacted authors of studies for clarification. We extracted the following data: (i) participant characteristics (age, sex, diagnosis, comorbidity, severity of illness, study setting); (ii) intervention details (intended dosage range, mean daily dosage actually prescribed, co‐intervention if any, sponsorship); and (iii) outcome measures of interest from the included studies. </p> <section id="CD003196-sec4-0010"> <h5 class="title">Main comparisons</h5> <p> <ol id="CD003196-lst1-0005"> <li> <p>Valproate versus placebo.</p> </li> <li> <p>Valproate versus alternative mood stabiliser.</p> </li> <li> <p>Valproate versus other treatments (e.g. antipsychotics).</p> </li> <li> <p>Valproate plus mood stabiliser versus mood stabiliser alone.</p> </li> <li> <p>Valproate plus mood stabiliser versus valproate alone.</p> </li> </ol> </p> </section> </section> <section id="CD003196-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed trial quality in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). This set of criteria is based on evidence of associations between effect overestimation and high risk of bias in an article, such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. Categories are defined as low risk of bias, high risk of bias, and unclear risk of bias. </p> <p>If the raters disagreed, the final rating was made by consensus with involvement of another member of the review group. Non‐congruence in quality assessment was reported as percentage disagreement. </p> </section> <section id="CD003196-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>All comparisons were performed between valproate and comparator drug or placebo as individual compound. </p> <section id="CD003196-sec4-0011"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous, or event‐like, data, the risk ratio (RR) was calculated with its 95% confidence interval (CI). For statistically significant results, we calculated the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH) as the inverse of the risk difference. </p> </section> <section id="CD003196-sec4-0012"> <h5 class="title">Continuous data</h5> <p>For continuous data, mean differences (MDs) or standardised mean differences (SMDs) were calculated with 95% CIs. MDs were used when the same scale was used to measure an outcome; SMDs were employed when different scales were used to measure the same outcome. Continuous data on clinical outcomes often are not normally distributed, and skewed data were presented descriptively. If papers reported a mean and a standard deviation (SD), as well as an absolute minimum possible value for the outcome, we divided the mean by the SD. If this value was less than two, then we concluded that some indication of skewness was present. If the value was less than one (i.e. the SD was bigger than the mean), then skewness was almost certainly present. If papers did not report the skewness and simply reported means, SDs and sample sizes, these numbers were used. Because these data may not have been properly analysed and can be misleading, analyses were conducted with and without these studies. If the data were log‐transformed for analysis, and the geometric means were reported, skewness was reduced. This is the recommended method for analysis of skewed data (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> <section id="CD003196-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <section id="CD003196-sec4-0013"> <h5 class="title">Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs when an effect (e.g. pharmacological, physiological, psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, participants can differ systematically from their initial state, even despite a wash‐out phase. For this reason, we planned to use only data from the first phase of the cross‐over studies. No cross‐over studies were identified for this version of the review. Given that cross‐over trials for which only first period data are available should be considered to be at risk of bias (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>), careful attention will be paid to retrieve only unbiased data available from such studies in the next updates of this review. </p> </section> <section id="CD003196-sec4-0014"> <h5 class="title">Cluster‐randomised trials</h5> <p>No cluster randomised trials were found for this version of the review. Should they be identified in a future update, we will attempt to adjust for the effects of clustering using an intraclass correlation coefficient (ICC). In fact this is seldom available in published reports, so a common approach is to use external estimates obtained from similar studies; several resources are available that provide examples of ICC (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We will conduct sensitivity analyses to investigate the robustness of our conclusions, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. </p> </section> <section id="CD003196-sec4-0015"> <h5 class="title">Studies with multiple treatment groups</h5> <p>For a particular multi‐arm study, the intervention groups of relevance to a systematic review are all those that could be included in a pair‐wise comparison of intervention groups that, if investigated alone, would meet the criteria for inclusion of studies in the review. Each meta‐analysis addresses only a single pair‐wise comparison, so we first considered whether a study of each possible pair‐wise comparison of interventions in the study was eligible for the meta‐analysis. Then, several possible approaches to including a study with multiple intervention groups could be used in a particular meta‐analysis (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). For binary outcomes, we decided to combine all relevant experimental intervention groups of the study into a single experimental group, and to combine all relevant control intervention groups into a single control group. For continuous outcomes, we decided to combine means and standard deviations using methods described in Chapter 7 of the <i>Cochrane Handbook for Systematic Review of Interventions</i>. </p> </section> </section> <section id="CD003196-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Binary outcomes were calculated on a strict intention‐to‐treat (ITT) basis: Dropouts were included in this analysis. When data were missing and the method of "last observation carried forward" (LOCF) had been used to do an ITT analysis, then the LOCF data were used. When standard deviations (SDs) were missing, we presented data descriptively. When SDs were not reported, authors were asked to supply the data. When only the standard error (SE) or <i>t</i>‐statistics or the P value was reported, we calculated SDs in accordance with <a href="./references#CD003196-bbs2-0016" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200. ">Altman 1996</a>. </p> </section> <section id="CD003196-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity between studies was investigated by the I<sup>2</sup> statistic (<a href="./references#CD003196-bbs2-0044" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. British Medical Journal2003;327(7414):557‐60. ">Higgins 2003</a>) (I<sup>2</sup> equal to or greater than 50% was considered indicative of heterogeneity) and by visual inspection of the forest plots. Given that the value of I<sup>2</sup> depends on the sample size of the included studies, the magnitude and direction of effects and the strength of evidence for heterogeneity, we used this arbitrary threshold to perform a preliminary evaluation. If the I<sup>2</sup> value fell below 50% but the direction and magnitude of treatment effects were suggestive of important heterogeneity, we investigated the potential sources of heterogeneity. </p> </section> <section id="CD003196-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>Data from included studies were entered into a funnel plot (trial effect against trial variance) for investigation of small‐study effects (<a href="./references#CD003196-bbs2-0067" title="SterneJA , GavaghanD , EggerM . Publication and related bias in meta‐analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology2000;53(11):1119‐29. [PUBMED: 11106885] ">Sterne 2000</a>). We planned to use the tests for funnel plot asymmetry only when at least 10 studies were included in the meta‐analysis (<a href="./references#CD003196-bbs2-0045" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). Funnel plot asymmetry may be noted for many possible reasons, so when evidence of small‐study effects was identified, all possible reasons for funnel plot asymmetry, including publication bias, were investigated. </p> </section> <section id="CD003196-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>All analyses used a fixed‐effect model. We decided to use a fixed‐effect model as the primary analysis because by including only RCTs with standardised dose regimens, similar clinical management and narrow diagnostic inclusion criteria, we did not expect to see significant clinical heterogeneity. However, the robustness of this summary measure was routinely examined by checking the random‐effects model, which has the greatest generalisability in our empirical examination of summary effect measures for meta‐analyses (<a href="./references#CD003196-bbs2-0036" title="FurukawaTA , GuyattGH , GriffithLE . Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta‐analyses. International Journal of Epidemiology2002;31(1):72‐6. ">Furukawa 2002a</a>). Material differences between the models were reported. A P value less than 0.05 and a 95% confidence interval (CI) were considered statistically significant. </p> </section> <section id="CD003196-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses for primary outcomes when possible.</p> <p> <ol id="CD003196-lst1-0006"> <li> <p>Studies examining rapid cycling bipolar disorder were to be considered separately. The efficacy of valproate in preventing/attenuating episodes in rapid cycling disorder was measured by recurrence of affective episodes; admission to hospital; institution of additional treatment for mood disorder; and length of the well period, expressed in cycle lengths. </p> </li> <li> <p>Assessment of the effectiveness of valproate treatment in previous mood stabiliser non‐responders was considered. </p> </li> </ol> </p> <p>Results were interpreted with caution because multiple comparisons can lead to false‐positive conclusions (<a href="./references#CD003196-bbs2-0059" title="OxmanAD , GuyattGH . A consumer's guide to subgroup analyses. Annals of Internal Medicine1992;116(1):78‐84. ">Oxman 1992</a>). If the CIs of RRs in the groups did not overlap, potential sources of heterogeneity were investigated. Given that no age restrictions were applied in the present review, in the next update we will conduct, if possible, subgroup analyses for age, as important differences between children/adolescents and adults could be seen in terms of clinical presentation. </p> </section> <section id="CD003196-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>The following sensitivity analyses for primary outcomes were planned a priori<i>.</i> </p> <p> <ol id="CD003196-lst1-0007"> <li> <p>We excluded trials with unclear concealment of random allocation and/or unclear double blinding. </p> </li> <li> <p>We excluded trials with a dropout rate greater than 20%.</p> </li> <li> <p>We excluded studies with a discontinuation design. Data from these studies were to be analysed separately for assessment of the effects of valproate discontinuation. </p> </li> <li> <p>The routine application of random‐effects and fixed‐effect models can be considered an additional form of sensitivity analysis. </p> </li> <li> <p>The use of ITT analyses, when data have been imputed (by you or by the trialists), warrants sensitivity analyses. In future updates, we will undertake sensitivity analysis in the event that we will impute data for ITT analysis. </p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003196-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003196-sec1-0004"></div> <section id="CD003196-sec2-0008"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD003196-sec2-0018" title="">Characteristics of included studies</a>; <a href="./references#CD003196-sec2-0019" title="">Characteristics of excluded studies</a>; and <a href="./references#CD003196-sec2-0020" title="">Characteristics of studies awaiting classification</a>. </p> <section id="CD003196-sec3-0018"> <h4 class="title">Results of the search</h4> <p>Initially, we identified 59 new references through the updated search. After the abstracts were read, 30 references were considered relevant for our review and were retrieved for more detailed evaluation (see <a href="#CD003196-fig-0001">Figure 1</a> for PRISMA flow diagram). Although the search was thorough, it is possible that unpublished studies may not have been identified. </p> <div class="figure" id="CD003196-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram showing study selection process." data-id="CD003196-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram showing study selection process.</p> </div> </div> </div> </section> <section id="CD003196-sec3-0019"> <h4 class="title">Included studies</h4> <p>A total of six studies were identified, with a mean follow‐up duration ranging between 6 and 24 months. Attempts to contact trial authors for additional unpublished information were successful in five cases, and additional data were provided by the authors of three studies (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). </p> <section id="CD003196-sec4-0016"> <h5 class="title">Study design</h5> <p>Most studies were reported to be double‐blind (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), apart from <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a> and <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>, which were designed as open‐label studies. Only two studies were three‐arm trials (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>), and the remaining four were two‐armed studies (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). </p> </section> <section id="CD003196-sec4-0017"> <h5 class="title">Sample Size</h5> <p>Overall, 876 participants were included. The mean sample size per arm was 60.5 participants (range 10 to 187). Four studies recruited fewer than 100 participants (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), and only two studies recruited more than 200 participants overall (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). </p> </section> <section id="CD003196-sec4-0018"> <h5 class="title">Setting/participants</h5> <p>Five trials enrolled only outpatients (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), and one study enrolled both inpatients and outpatients (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). All participants had been given a formal diagnosis of bipolar disorder according to <i>DSM‐IV</i> (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) or <i>DSM‐III‐R</i> (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>); however, one study (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>) recruited a few participants with schizoaffective disorder (3 of 23 randomly assigned participants). One study recruited children and adolescents only (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>), and two trials randomly assigned only participants with rapid cycling disorder (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). In <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>, participants had co‐occurring substance abuse or dependence. About three‐fifths of the participants included in the study recruiting children and adolescents only (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>) were prescribed concomitant psychostimulants for attention deficit hyperactivity disorder (ADHD) symptoms (35 of 60, 58.3%), but randomisation was stratified on the basis of three factors: age (5 to 11 or 12 to 17 years), presence/absence of rapid cycling and whether the individual had comorbid ADHD. All studies employed a discontinuation design (randomly assigning participants before long‐term, relapse prevention treatment was provided). </p> </section> <section id="CD003196-sec4-0019"> <h5 class="title">Interventions and comparators</h5> <p>We found two studies (overall, 312 participants) that compared valproate with placebo (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), four studies (overall, 618 participants) comparing valproate with lithium (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>), one study (overall, 23 participants) comparing valproate with olanzapine (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>) and one study (overall, 220 participants) comparing valproate with the combination of valproate plus lithium (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). In the included studies, almost all participants used lithium or valproate within the therapeutic dose range. Valproate or divalproex as orally administered was used in all trials. Blood levels of valproate were monitored in all trials. The tapering discontinuation of medications in the run‐up to maintenance treatment was explicitly gradual in <a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> (two weeks), <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> (average six weeks), <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> (eight weeks) and <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> and <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a> (four weeks), presumably to avoid rebound. <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a> recruited participants who were euthymic at the moment of recruitment, with no run‐in phase. Rescue medications were allowed in all studies in accordance with a priori protocols. </p> </section> <section id="CD003196-sec4-0020"> <h5 class="title">Outcomes</h5> <p>Of the included six studies, all reported efficacy data and tolerability or acceptability data that were suitable for meta‐analysis. The included studies did not report on all outcomes prespecified in the protocol of this review. Outcomes of clear relevance to patients and clinicians, in particular, patients' and their relatives' attitudes towards treatment, patients' ability to return to work and resume normal social functioning, health‐related quality of life measures and costs of health care services, were not reported in the included studies. </p> </section> </section> <section id="CD003196-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>Of the 30 references retrieved for more detailed evaluation, 24 articles did not meet our inclusion criteria and were excluded for one of the following reasons: wrong/non‐randomised design (13 articles), review/case series (two articles), wrong comparison (five articles) and wrong diagnosis/population (four articles) (see <a href="#CD003196-fig-0001">Figure 1</a> for PRISMA flow diagram). </p> <section id="CD003196-sec4-0021"> <h5 class="title">Ongoing studies</h5> <p>No ongoing studies were identified.</p> </section> <section id="CD003196-sec4-0022"> <h5 class="title">Studies awaiting classification</h5> <p>Two studies are awaiting classification. Bowden 2012 was identified after the search date, so has not been formally considered for inclusion. If it meets all the inclusion criteria it will be included in a subsequent update of this review. We require further information to assess NCT00071253. If we receive the required information we will be able to consider its eligibility when updating this review. </p> </section> <section id="CD003196-sec4-0023"> <h5 class="title">New studies found at this update</h5> <p>Five new studies were incorporated at this update: <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>; and <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>. </p> </section> </section> </section> <section id="CD003196-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD003196-bbs1-0001" title="">Included studies</a>, <a href="#CD003196-fig-0002">Figure 2</a> and <a href="#CD003196-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD003196-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003196-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD003196-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies." data-id="CD003196-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies. </p> </div> </div> </div> <p>Our judgement about the overall risk of bias in the individual studies is illustrated in <a href="#CD003196-fig-0002">Figure 2</a> and <a href="#CD003196-fig-0003">Figure 3</a>. No disagreement between the raters occurred. The methodological quality of these included studies was questionable overall. Even though it is not possible to predict the direction or magnitude of bias associated with lack of adequate sequence generation or adequate allocation concealment (<a href="./references#CD003196-bbs2-0057" title="Odgaard‐JensenJ , VistGE , TimmerA , KunzR , AklEA , SchünemannH , et al. Randomisation to protect against selection bias in healthcare trials. Cochrane Database of Systematic Reviews2011, Issue 4. [DOI: 10.1002/14651858.MR000012.pub3] ">Odgaard‐Jensen 2011</a>), this type of reporting has been associated with an overestimate of the effect of investigational drugs (<a href="./references#CD003196-bbs2-0065" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of American Medical Association1995;273(5):408–12. ">Schulz 1995</a>), and this should be considered when the review results are interpreted. </p> <section id="CD003196-sec3-0021"> <h4 class="title">Allocation</h4> <p>In terms of random sequence generation, we found that all included studies were at low risk of bias, and most studies reported that the method of generating random sequence was “a computer originated schedule”. In terms of "allocation concealment", only one study reported enough details on the allocation concealment procedure (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). We were not assured that bias was minimised during the allocation procedure in the other five studies (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), yet the great majority of them reported that participants allocated to each treatment group were “similar”, “the same”, “not significantly different”, “comparable” or “matched”. </p> </section> <section id="CD003196-sec3-0022"> <h4 class="title">Blinding</h4> <p>Four of six included studies described their design as “double‐blind” (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>); however, no tests were conducted to ensure successful blinding. Two studies reported full details about blinding of participants and personnel and were rated at low risk of bias (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), and two studies had been carried out in an open manner (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). Blinding of outcome assessment was rated as "unclear" in five studies (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). </p> </section> <section id="CD003196-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p>Only three studies were rated as at "low risk" of bias (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). Total dropout rate was high overall, ranging from 20.9% (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) to 90% (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>). In four studies, the total dropout rates were higher than 50% (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). Two studies used a proper ITT analysis and were rated as "low risk" (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>), and the remaining four did not provide clear information about analysis and were rated "unclear" (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). </p> </section> <section id="CD003196-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>Two studies were rated as "low risk" (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) and one as "high risk" (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>). The study protocol was available for only one study (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>), and some trials did not report in the published paper SDs for mean changes as continuous outcomes (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>). </p> </section> <section id="CD003196-sec3-0025"> <h4 class="title">Other potential sources of bias</h4> <p>One study was sponsored by a valproate manufacturer (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>), one study reported no information about funding (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>) and all remaining studies were funded by grants from independent bodies (e.g. the National Institutes of Health, the Stanley Medical Research Institute, or the Stanley Foundation, and the Nina Rahn Fund). In three of these studies, medications were provided by Abbott Laboratories or Abbott Pharmaceuticals, the manufacturer of valproate (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), and in the fourth study, all study drugs (both lithium carbonate and valproate semisodium) were donated by sanofi‐aventis (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). </p> </section> </section> <section id="CD003196-sec2-0010"> <h3 class="title" id="CD003196-sec2-0010">Effects of interventions</h3> <p>All six included studies contributed usable data for the efficacy, acceptability and tolerability analyses, but only one reported data about quality of life and global functioning (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). No studies assessed other general health and social functioning issues, such as employment or separation/divorce, and no information about costs of healthcare services was provided in the included studies. All included studies excluded women who were pregnant (or were planning to become pregnant) and fertile women not on adequate contraceptive methods. No cases of teratogenicity were signalled. The results of the present systematic review are reported by comparison and by outcome, in accordance with the original review protocol. The forest plots are organised according to relevance of outcomes, as reported in the review protocol. For tolerability, adverse events are reported only when statistically significant (non–statistically significant results about adverse events are presented in <a href="#CD003196-tbl-0006">Table 1</a>). </p> <div class="table" id="CD003196-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Adverse event</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Valproate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Comparator</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Risk Ratio, Fixed [95% CI]</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b><i>Valproate vs placebo</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acne</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 [0.01, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akathisia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.03, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blurred vision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.13 [0.22, 21.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.17, 6.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 [0.78, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dry mouth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.44 [0.42, 132.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.33 [0.70, 40.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased appetite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 [0.01, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.42 [0.88, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32 [0.94, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polydipsia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.28 [0.49, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polyuria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.38, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sedation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19 [0.86, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sexual dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.17, 6.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tachycardia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.03, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thirst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.32, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tinnitus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.03 [0.80, 45.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b><i>Valproate vs lithium</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akathisia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [0.01, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alopecia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.74 [0.85, 3.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balance problems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.29 [0.22, 23.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive difficulties</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.02, 8.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased appetite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 [0.22, 4.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dry eyes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07 [0.00, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 [0.03, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 [0.10, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haematological dyscrasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 [0.13, 70.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.64 [0.96, 7.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 [0.68, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40 [0.46, 4.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sore throat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 [0.33, 27.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.02, 8.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stomach pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.33 [0.67, 8.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tachycardia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [0.01, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tremor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.65, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Upper respiratory congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Visual impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.16 [0.01, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 [0.10, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weight gain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 [0.89, 2.85]</p> </td> </tr> </tbody> </table> </div> <section id="CD003196-sec3-0026"> <h4 class="title">Comparison 1: valproate versus placebo</h4> <section id="CD003196-sec4-0024"> <h5 class="title">Primary outcome</h5> <section id="CD003196-sec5-0001"> <h6 class="title">1.1 Efficacy in preventing/attenuating further episodes of affective disorder</h6> <p>Valproate was more effective than placebo in preventing study withdrawal due to any mood episode (RR 0.68, 95% CI 0.49 to 0.93; P = 0.02; NNTB 8, 95% CI 5 to 50; 2 RCTs, 312 participants) or to a depressive episode alone (RR 0.46, 95% CI 0.24 to 0.89; P = 0.02; NNTB 13, 95% CI 7 to 100; 2 RCTs, 312 participants) (<a href="./references#CD003196-fig-00101" title="">Analysis 1.1</a>; <a href="#CD003196-fig-0004">Figure 4</a>). No strong evidence suggested that valproate was superior to placebo in reducing study withdrawals due to manic episodes (RR 0.77, 95% CI 0.48 to 1.25; P = 0.29; 2 RCTs, 312 participants) (<a href="./references#CD003196-fig-00101" title="">Analysis 1.1</a>; <a href="#CD003196-fig-0004">Figure 4</a>). When study data were analysed using the random‐effects model, valproate was still seen to more effective than placebo in preventing study withdrawal due to any mood episode, but results were no more statistically significant (RR 0.71, 95% CI 0.49 to 1.02; P = 0.07). </p> <div class="figure" id="CD003196-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Valproate versus placebo, outcome: 1.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Valproate versus placebo, outcome: 1.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> </div> </section> </section> <section id="CD003196-sec4-0025"> <h5 class="title">Secondary outcomes</h5> <section id="CD003196-sec5-0002"> <h6 class="title">1.2 Acceptability of treatments</h6> <p>Valproate was more effective than placebo in preventing all‐cause study withdrawal (RR 0.82, 95% CI 0.71 to 0.95; P = 0.01; NNTB 8, 95% CI 5 to 34; 2 RCTs, 312 participants) (<a href="./references#CD003196-fig-00102" title="">Analysis 1.2</a>), but it was associated with a greater number of participants dropping out of treatment as the result of intolerance or non‐compliance (RR 1.87, 95% CI 1.01 to 3.47; P = 0.05; NNTH 10, 95% CI 6 to 100; 1 RCT, 281 participants) (<a href="./references#CD003196-fig-00103" title="">Analysis 1.3</a>). No data were provided about participant reports of satisfaction or otherwise with treatment. </p> </section> <section id="CD003196-sec5-0003"> <h6 class="title">1.3 Adverse effects</h6> <p>People allocated to valproate were more likely to have tremor (RR 2.41, 95% CI 1.58 to 3.67; P &lt; 0.0001; NNTH 10, 95% CI 6 to 34; 2 RCTs, 312 participants; I<sup>2</sup> = 90%) (<a href="./references#CD003196-fig-00104" title="">Analysis 1.4</a>), weight gain (RR 2.04, 95% CI 1.07 to 3.86; P = 0.03; NNTH 4, 95% CI 3 to 7; 2 RCTs, 312 participants; I<sup>2</sup> = 80%) and alopecia (RR 2.51, 95% CI 1.15 to 5.51; NNTH 10, 95% CI 6 to 34; P = 0.02; 2 RCTs, 312 participants). However, the differences in tremor and weight gain disappeared when the random‐effects model was used (RR 1.85, 95% CI 0.54 to 6.33; P = 0.33 and RR 1.25, 95% CI 0.19 to 7.94; P = 0.82, respectively). </p> </section> <section id="CD003196-sec5-0004"> <h6 class="title">1.4 General health and social functioning</h6> <p>No studies reported on this outcome for this comparison.</p> </section> <section id="CD003196-sec5-0005"> <h6 class="title">1.5 Mortality rates and deliberate self‐harm</h6> <p>No data about mortality or suicide were reported.</p> </section> </section> </section> <section id="CD003196-sec3-0027"> <h4 class="title">Comparison 2: valproate versus lithium</h4> <section id="CD003196-sec4-0026"> <h5 class="title">Primary outcome</h5> <section id="CD003196-sec5-0006"> <h6 class="title">2.1 Efficacy in preventing/attenuating further episodes of affective disorder</h6> <p>No strong evidence indicated that valproate was inferior or superior to lithium in preventing study withdrawals due to episodes of mood disorder (any mood episode or manic, depressive hypomanic or mixed episode alone) (<a href="./references#CD003196-fig-00201" title="">Analysis 2.1</a>; <a href="#CD003196-fig-0005">Figure 5</a>). One study (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) reported detailed information about other dichotomous efficacy outcomes, such as number of hospital admissions (<a href="./references#CD003196-fig-00202" title="">Analysis 2.2</a>) or new treatment for mood episode (<a href="./references#CD003196-fig-00203" title="">Analysis 2.3</a>). No difference was found between valproate and lithium on these outcomes, with the exception of "new treatment for depressive episode", for which valproate was noted to be inferior to lithium (RR 1.43, 95% CI 1.02 to 2.01; P = 0.04; NNTH 8, 95% CI 4 to 100; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00203" title="">Analysis 2.3</a>). Another study reported the continuous outcome "time to relapse" (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>), but we do not know whether valproate was better than lithium in terms of time to median survival (as measured in days) for participants who relapsed because of the presence of mood symptoms (MD ‐2.00, 95% CI ‐7.24 to 3.24; P = 0.45: 1 RCT, 60 participants) (<a href="./references#CD003196-fig-00204" title="">Analysis 2.4</a>). </p> <div class="figure" id="CD003196-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Valproate versus lithium, outcome: 2.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Valproate versus lithium, outcome: 2.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> </div> </section> </section> <section id="CD003196-sec4-0027"> <h5 class="title">Secondary outcomes</h5> <section id="CD003196-sec5-0007"> <h6 class="title">2.2 Acceptability of treatments</h6> <p>When compared with lithium, valproate was associated with a lesser number of participants dropping out of treatment for any cause (RR 0.87, 95% CI 0.77 to 0.98; P = 0.02; 4 RCTs, 618 participants) (<a href="./references#CD003196-fig-00205" title="">Analysis 2.5</a>) and because of intolerance or non‐compliance (RR 0.67, 95% CI 0.49 to 0.93; P = 0.02; 4 RCTs, 618 participants) (<a href="./references#CD003196-fig-00206" title="">Analysis 2.6</a>). </p> </section> <section id="CD003196-sec5-0008"> <h6 class="title">2.3 Adverse effects</h6> <p>People allocated to valproate were less likely to have diarrhoea (RR 0.74, 95% CI 0.55 to 0.99; NNTB 10, 95% CI 5 to ∞; P = 0.04; 2 RCTs, 338 participants), polyuria (RR 0.31, 95% CI 0.16 to 0.58; P = 0.0003; NNTB 7, 95% CI 5 to 15; 2 RCTs, 338 participants; I<sup>2</sup> = 63%), increased thirst (RR 0.32, 95% CI 0.15 to 0.65; P = 0.002; NNTB 9, 95% CI 6 to 25; 2 RCTs, 338 participants) or enuresis (RR 0.22, 95% CI 0.05 to 0.94; P = 0.04; NNTB 5, 95% CI 3 to 20; 1 RCT, 60 participants) but were more likely to have sedation (RR 1.45, 95% CI 1.00 to 2.10; P = 0.05; NNTH 9, 95% CI 5 to 100; 2 RCTs, 338 participants; I<sup>2</sup> = 59%) or infection (RR 2.07, 95% CI 1.16 to 3.68; P = 0.01; NNTH 8, 95% CI 5 to 20; 1 RCT, 278 participants) (<a href="./references#CD003196-fig-00207" title="">Analysis 2.7</a>). However, the differences for sedation and polyuria disappeared when the random‐effects model was used (RR 0.93, 95% CI 0.20 to 4.44; P = 0.93 and RR 0.21, 95% CI 0.02 to 1.89; P = 0.16, respectively). </p> </section> <section id="CD003196-sec5-0009"> <h6 class="title">2.4 General Health and Social Functioning</h6> <p>Only one study (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) reported data about quality of life and global functioning, but the results were inconclusive (<a href="./references#CD003196-fig-00208" title="">Analysis 2.8</a>; <a href="./references#CD003196-fig-00209" title="">Analysis 2.9</a>). </p> </section> <section id="CD003196-sec5-0010"> <h6 class="title">2.5 Mortality rates and deliberate self harm</h6> <p>Only one study (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) reported data about mortality and deliberate self‐harm (DSH). We do not know whether valproate was worse than lithium in terms of DSH (RR 2.50, 95% CI 0.50 to 12.61; P = 0.27; 1 RCT, 220 participants; <a href="./references#CD003196-fig-00210" title="">Analysis 2.10</a>) or number of deaths (RR 1.50, 95% CI 0.26 to 8.80; P = 0.65; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00211" title="">Analysis 2.11</a>). None of the deaths was caused by suicide. </p> </section> </section> </section> <section id="CD003196-sec3-0028"> <h4 class="title">Comparison 3: valproate versus olanzapine</h4> <section id="CD003196-sec4-0028"> <h5 class="title">Primary outcome</h5> <section id="CD003196-sec5-0011"> <h6 class="title">3.1 Efficacy in preventing/attenuating further episodes of affective disorder</h6> <p>We do not know whether valproate was better than olanzapine in terms of numbers of participants experiencing syndromic recurrence of any mood episode (meeting <i>DSM‐IV</i> criteria) (RR 0.74, 95% CI 0.30 to 1.85, P = 0.52; 1 trial, 23 participants) (<a href="./references#CD003196-fig-00301" title="">Analysis 3.1</a>). No strong evidence suggested that valproate was inferior or superior to olanzapine in preventing study withdrawals due to episodes of mood disorder (manic or depressive episodes) (<a href="./references#CD003196-fig-00301" title="">Analysis 3.1</a>). </p> </section> </section> <section id="CD003196-sec4-0029"> <h5 class="title">Secondary outcomes</h5> <section id="CD003196-sec5-0012"> <h6 class="title">3.2 Acceptability of treatments</h6> <p>In the included study (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>), all dropouts left the study because of side effects, and all belonged to the olanzapine group. However, it is unclear whether there was a difference between valproate and olanzapine in terms of numbers of participants withdrawing from treatment (RR 0.18, 95% CI 0.01 to 3.16, P = 0.24; 1 trial, 23 participants) (<a href="./references#CD003196-fig-00302" title="">Analysis 3.2</a>; <a href="./references#CD003196-fig-00303" title="">Analysis 3.3</a>). </p> </section> <section id="CD003196-sec5-0013"> <h6 class="title">3.3 Adverse effects</h6> <p>No clear data were available in the paper that reported only that adverse events causing premature discontinuation for three participants allocated to olanzapine were weight gain and sedation. </p> </section> <section id="CD003196-sec5-0014"> <h6 class="title">3.4 General Health and Social Functioning </h6> <p>No studies reported on this outcome for this comparison.</p> </section> <section id="CD003196-sec5-0015"> <h6 class="title">3.5 Mortality rates and deliberate self harm</h6> <p>No deaths during the treatment period were reported in the included study (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>). </p> </section> </section> </section> <section id="CD003196-sec3-0029"> <h4 class="title">Comparison 4: valproate plus lithium versus lithium alone</h4> <section id="CD003196-sec4-0030"> <h5 class="title">Primary outcome</h5> <section id="CD003196-sec5-0016"> <h6 class="title">4.1 Efficacy in preventing/attenuating further episodes of affective disorder</h6> <p>There was no evidence that valproate plus lithium was superior to lithium alone in preventing study withdrawals due to episodes of mood disorder (<a href="./references#CD003196-fig-00401" title="">Analysis 4.1</a>). No differences were found between valproate plus lithium and lithium alone in terms of hospital admission or new drug treatment for mood episode (<a href="./references#CD003196-fig-00402" title="">Analysis 4.2</a>; <a href="./references#CD003196-fig-00403" title="">Analysis 4.3</a>). </p> </section> </section> <section id="CD003196-sec4-0031"> <h5 class="title">Secondary outcomes</h5> <section id="CD003196-sec5-0017"> <h6 class="title">4.2 Acceptability of treatments</h6> <p>Even though it was not clear whether there was a difference between the combination of lithium and valproate and lithium alone in terms of all‐cause dropout (<a href="./references#CD003196-fig-00404" title="">Analysis 4.4</a>), lithium alone was associated with dropout from treatment of a lesser number of participants as the result of intolerance or non‐compliance when compared with lithium and valproate, but results were inconclusive (RR 1.83, 95% CI 0.70 to 4.78; P = 0.22; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00405" title="">Analysis 4.5</a>). </p> </section> <section id="CD003196-sec5-0018"> <h6 class="title">4.3 Adverse effects</h6> <p>No evidence indicates that valproate plus lithium differed from lithium alone in causing serious adverse events (<a href="./references#CD003196-fig-00406" title="">Analysis 4.6</a>). </p> </section> <section id="CD003196-sec5-0019"> <h6 class="title">4.4 General health and social functioning </h6> <p>No difference was found between lithium and valproate in terms of quality of life or global functioning (<a href="./references#CD003196-fig-00407" title="">Analysis 4.7</a>; <a href="./references#CD003196-fig-00408" title="">Analysis 4.8</a>). </p> </section> <section id="CD003196-sec5-0020"> <h6 class="title">4.5 Mortality rates and deliberate self‐harm</h6> <p>Fewer participants in the lithium alone group committed DSH, but the results were inconclusive (RR 2.00, 95% CI 0.37 to 10.70; P = 0.42; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00409" title="">Analysis 4.9</a>). Three participants died: one in the combination arm and two in the lithium alone arm (<a href="./references#CD003196-fig-00410" title="">Analysis 4.10</a>). </p> </section> </section> </section> <section id="CD003196-sec3-0030"> <h4 class="title">Comparison 5: valproate plus lithium versus valproate alone</h4> <section id="CD003196-sec4-0032"> <h5 class="title">Primary outcome</h5> <section id="CD003196-sec5-0021"> <h6 class="title">5.1 Efficacy in preventing/attenuating further episodes of affective disorder</h6> <p>Valproate plus lithium was superior to valproate alone in prevention of study withdrawals due to episodes of mood disorder (RR 0.78, 95% CI 0.63 to 0.96; P = 0.02; NNTB 7, 95% CI 4 to 34; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00501" title="">Analysis 5.1</a>; <a href="#CD003196-fig-0006">Figure 6</a>); this combination also resulted in lesser numbers of participants who required new treatment for any mood episode (RR 0.77, 95% CI 0.62 to 0.96; P = 0.02; NNTB 7, 95% CI 4 to 34; 1 RCT, 220 participants) or for mania alone (RR 0.61, 95% CI 0.42 to 0.89; P = 0.009; NNTB 6, 95% CI 4 to 20; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00503" title="">Analysis 5.3</a>). The combination of lithium and valproate was also more effective than valproate alone in terms of hospital admissions or new drug treatments for depression, but these results were inconclusive (<a href="./references#CD003196-fig-00502" title="">Analysis 5.2</a>; <a href="./references#CD003196-fig-00503" title="">Analysis 5.3</a>). </p> <div class="figure" id="CD003196-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Valproate plus lithium versus valproate alone, outcome: 5.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Valproate plus lithium versus valproate alone, outcome: 5.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> </div> </section> </section> <section id="CD003196-sec4-0033"> <h5 class="title">Secondary outcomes</h5> <section id="CD003196-sec5-0022"> <h6 class="title">5.2 Acceptability of treatments</h6> <p>Even though it was not clear whether there was a difference between the combination of lithium and valproate and valproate alone in terms of all‐cause dropout (<a href="./references#CD003196-fig-00504" title="">Analysis 5.4</a>), valproate alone was associated with lesser numbers of participants dropping out of treatment as the result of intolerance or non‐compliance when compared with the combination of lithium and valproate, but the results were inconclusive (RR 2.75, 95% CI 0.90 to 8.37; P = 0.07; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00505" title="">Analysis 5.5</a>). </p> </section> <section id="CD003196-sec5-0023"> <h6 class="title">5.3 Adverse effects</h6> <p>No evidence indicated that valproate plus lithium was more likely than valproate alone to cause serious adverse events (<a href="./references#CD003196-fig-00506" title="">Analysis 5.6</a>). </p> </section> <section id="CD003196-sec5-0024"> <h6 class="title">5.4 General health and social functioning </h6> <p>No difference between combination lithium plus valproate and valproate alone was noted in terms of quality of life or global functioning (<a href="./references#CD003196-fig-00507" title="">Analysis 5.7</a>; <a href="./references#CD003196-fig-00508" title="">Analysis 5.8</a>). </p> </section> <section id="CD003196-sec5-0025"> <h6 class="title">5.5 Mortality rates and deliberate self‐harm</h6> <p>Fewer participants in the combination group died, but the results were inconclusive (RR 0.33, 95% CI 0.04 to 3.16; P = 0.34; 1 RCT, 220 participants) (<a href="./references#CD003196-fig-00510" title="">Analysis 5.10</a>). Nine participants committed DSH: four in the combination arm and five in the valproate alone arm (<a href="./references#CD003196-fig-00509" title="">Analysis 5.9</a>). </p> </section> </section> </section> <section id="CD003196-sec3-0031"> <h4 class="title">Subgroup analyses</h4> <section id="CD003196-sec4-0034"> <h5 class="title">1) Rapid cycling bipolar disorder</h5> <p>We did not find enough studies to investigate the issue about rapid cycling disorder as reported in the review protocol because, of the two small trials randomly assigning participants with rapid cycling disorder only, one compared valproate as add‐on treatment with placebo (<a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a>), and the second compared valproate as monotherapy with lithium (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>). </p> </section> <section id="CD003196-sec4-0035"> <h5 class="title">2) Effectiveness of valproate treatment in previous mood stabiliser non‐responders</h5> <p>Information about participants who did not respond to other mood stabilisers, as reported in the included studies, was not sufficient to allow a proper statistical analysis. </p> </section> </section> <section id="CD003196-sec3-0032"> <h4 class="title">Funnel plot analysis</h4> <p>For all comparisons, the presence of publication bias was not examined because trials were insufficient to allow meaningful formal assessment with the use of funnel plots. </p> </section> <section id="CD003196-sec3-0033"> <h4 class="title">Sensitivity analyses</h4> <section id="CD003196-sec4-0036"> <h5 class="title">1) Excluding trials with unclear concealment of random allocation and/or unclear double blinding </h5> <p>This sensitivity analysis was not performed because only one study reported clear details on concealment of random allocation (<a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>), and of four double‐blind studies, two studies reported full details on blinding, but one compared valproate with lithium (<a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>) and the other one compared valproate with placebo (<a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a>). </p> </section> <section id="CD003196-sec4-0037"> <h5 class="title">2) Excluding trials whose dropout rate was greater than 20%</h5> <p>This sensitivity analysis was not performed because in all studies, the dropout rate was greater than 20%. </p> </section> <section id="CD003196-sec4-0038"> <h5 class="title">3) Excluding trials with a discontinuation design</h5> <p>This sensitivity analysis was not performed because five of six included studies had a discontinuation design, and only <a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a> recruited participants who were euthymic at the moment of recruitment with no run‐in phase. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003196-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003196-sec1-0005"></div> <section id="CD003196-sec2-0011"> <h3 class="title" id="CD003196-sec2-0011">Summary of main results</h3> <p>This systematic review of six randomised controlled trials comparing valproate with placebo or other active drugs in the maintenance treatment of bipolar disorder showed that valproate is more effective than placebo in preventing study withdrawals due to an episode of mood disorder (especially, depressive episode), but it is not materially different from lithium in terms of overall efficacy. However, only two studies compared valproate with placebo, and in the study that had the larger sample, valproate was no better than placebo on the primary efficacy measure. No reliable evidence suggested a difference between valproate and lithium (pooled RR 1.02, 95% CI 0.87 to 1.20), although the confidence interval is consistent  with a 13% relative reduction in the risk in favour of valproate and a 20% reduction in the risk consistent with lithium. No statistically significant difference was noted between valproate and lithium in terms of prevention of manic episodes (RR 1.14, 95% CI 0.90 to 1.44) or depressive episodes (RR 1.12, 95% CI 0.84 to 1.49). In both cases, however, the direction of the effect favoured lithium, and a post hoc sensitivity analysis, including or excluding <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> (which used slightly different definitions of outcome), had no material effect on the overall estimate. The apparent benefit of valproate compared with placebo was of a similar size to the advantage of valproate plus lithium compared with lithium monotherapy. Taken together, these suggest that valproate has some preventative efficacy in bipolar disorder. However, when compared with combination therapy with lithium, valproate alone did not show any clinical advantage, as combination therapy was more likely to prevent relapse than was monotherapy with valproate. Even though it was associated with a higher incidence of adverse events such as alopecia, tremor and weight gain than placebo, valproate was more acceptable than lithium, as it was associated with a lower risk for participants to withdraw from treatment. </p> </section> <section id="CD003196-sec2-0012"> <h3 class="title" id="CD003196-sec2-0012">Overall completeness and applicability of evidence</h3> <p>Retrieved randomised evidence compared valproate with a selection of possible comparator drugs, but only a few studies were found per comparison. The evidence that valproate is more effective than placebo was derived from only one moderately sized RCT and one very small RCT. By contrast, for the comparison between valproate and lithium, results were numerically more robust, as we found four RCTs. The identified studies were sufficient to address many, but not all, of the outcomes originally specified in the review protocol. </p> <p>In this review, we included only RCTs, and one of the main limitations of efficacy trials involves including participants far from the “real world”. Proper randomisations and reliable inclusion and exclusion criteria may help create two or more groups that do not differ. However, the external validity of study findings might be limited (<a href="./references#CD003196-bbs2-0025" title="CiprianiA , PurgatoM , BarbuiC . Why internal and external validity of experimental studies are relevant for clinical practice?. Epidemiology and Psychiatric Sciences2009;18(2):101‐3. ">Cipriani 2009a</a>). Generalisability of these findings can be extended only to patients who are likely to be enrolled in a randomised trial, and results from systematic reviews of RCTs should be integrated with available high‐quality observational evidence, which may inform better about the adverse events that cannot be fully assessed in RCTs only. </p> </section> <section id="CD003196-sec2-0013"> <h3 class="title" id="CD003196-sec2-0013">Quality of the evidence</h3> <p>With summary statistics, the quality of information is important for interpreting results and for usefulness of results in practice. Use of high‐quality research evidence is relevant for reviewing results and facilitating the translation of research in a way that can answer clinically relevant questions. However, the quality of RCTs is not easy to assess. Despite the fact that randomised clinical trials provide the best research design by which to answer questions about efficacy and acceptability of treatments (<a href="./references#CD003196-bbs2-0026" title="CiprianiA , GeddesJR . What is a randomised controlled trial?. Epidemiol Psichiatr Soc2009;18(3):191‐4. ">Cipriani 2009b</a>), the six studies included in this review (876 participants overall) failed to report key methodological issues. For example, a great majority of trials still do not report adequate information about allocation concealment. Meta‐analyses of poor‐quality studies may be seriously misleading (<a href="./references#CD003196-bbs2-0046" title="IoannidisJP . Why most published research findings are false. PLoS Medicine2005;2:e124. ">Ioannidis 2005</a>) because the bias associated with defects in the conduct of primary studies can seriously affect overall estimates of intervention. Even though reporting of outcomes in the included studies was sometimes unclear or incomplete (only graphs, no SDs), and the figures used for the analyses were not immediately understandable, the scant information about allocation concealment may be more a matter of reporting in the text than of real defects in study design. </p> </section> <section id="CD003196-sec2-0014"> <h3 class="title" id="CD003196-sec2-0014">Potential biases in the review process</h3> <p> <ul id="CD003196-lst1-0008"> <li> <p>Although the search was thorough, it is possible that unpublished studies have not been identified, but the small number of trials identified per comparison hinders the detection of any publication bias. We are also aware that a number of further randomised controlled trials comparing valproate with other drugs are currently being conducted and will be included in future updates of the review. </p> </li> </ul> <ul id="CD003196-lst1-0009"> <li> <p>For several comparisons, the data came from just one study (e.g. valproate vs olanzapine, valproate plus lithium vs valproate alone), and results from this review should be interpreted with caution. </p> </li> </ul> <ul id="CD003196-lst1-0010"> <li> <p>We found only one large placebo‐controlled RCT that investigated the efficacy and acceptability of valproate maintenance treatment in bipolar disorder. This study (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>) is one of the largest trials of maintenance therapy in bipolar disorder ever undertaken; however, the results are equivocal. The practical difficulties caused by the inclusion of a placebo‐treated group led to the inclusion of a less severely affected group of participants than is generally found in clinical practice. A higher relapse rate was anticipated than was actually found, which meant that the study had insufficient power to detect reliably a moderate, but clinically important, treatment effect. Moreover, a 52‐week follow‐up was probably rather short for a maintenance study. Despite its short duration, a large number of participants withdrew from the study, especially in the lithium group. Finally, during the up to 3‐month run‐in phase, the index manic episode was treated at the discretion of the investigator, and 117 participants had been treated with valproate only (31.5%), 124 with lithium only (33.3%), 50 with both drugs (usually sequentially) (13.4%) and 81 with neither drug (21.8%). Given that 187 participants were subsequently randomly assigned to valproate, 91 to lithium and 94 to placebo (2:1:1 randomisation scheme), and that participants taking valproate or lithium on the day of randomisation had the drug gradually withdrawn over a 2‐week time, this design might have favoured valproate over placebo and lithium. The primary analysis used in <a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> was a comparison of survival curves in the treatment arms. This primary analysis found no significant differences between treatment groups, although the comparison between lithium and valproate tended to favour the latter. In our analysis, without access to individual participant data, we simply used the number of participants leaving the study because of recurrence during the study. We found a statistically significant benefit for valproate compared with placebo. This result is rather surprising because the time‐to‐event analysis is more efficient. In other words, because it makes fuller use of the data, other things being equal, it is more likely to detect an effect should one exist. It is possible that the discrepancy is explained by the large number of dropouts, which occurred at different rates in each arm, and the number of censored observations. Therefore, although our analysis suggests that valproate is more efficacious than placebo in preventing mood episodes, the effect is not robust to the choice of analysis, and the true efficacy of valproate therefore remains uncertain. </p> </li> </ul> <ul id="CD003196-lst1-0011"> <li> <p>According to review protocol, we included non‐blind studies (<a href="./references#CD003196-bbs2-0001" title="AltamuraAC , RussoM , VismaraS , MundoE . Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinincal Psychopharmacology2004;24:454‐6. ">Altamura 2004</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>). As all RCTs used an open‐label design, outcome assessment should be done very carefully to reduce the risk of performance and ascertainment biases. In <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>, this risk was managed by restriction of randomisation to participants for whom there was no strong treatment preference on the part of the participant or the clinician and by careful verification of outcomes: All outcome events were considered by the trial management team, who were masked to treatment assignment, and in the case of any doubt, a description of the event was sent to an independent adjudication team. </p> </li> </ul> <ul id="CD003196-lst1-0012"> <li> <p>We considered the all‐cause discontinuation rate as a measure of acceptability of treatment. Even though it has been employed in many other systematic reviews in the field of long‐term treatment for bipolar disorder (<a href="./references#CD003196-bbs2-0028" title="CiprianiA , RendellJM , GeddesJ . Olanzapine in long‐term treatment for bipolar disorder. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD004367.pub2] ">Cipriani 2009d</a>; <a href="./references#CD003196-bbs2-0029" title="CiprianiA , RendellJ , GeddesJR . Olanzapine in the long‐term treatment of bipolar disorder: a systematic review and meta‐analysis. Journal of Psychopharmacology2010;24(12):1729‐38. ">Cipriani 2010</a>) and also for unipolar depression (<a href="./references#CD003196-bbs2-0055" title="NakagawaA , WatanabeN , OmoriIM , BarbuiC , CiprianiA , McGuireH , et al. Milnacipran versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006529.pub2] ">Nakagawa 2009</a>; <a href="./references#CD003196-bbs2-0027" title="CiprianiA , LaFerlaT , FurukawaTA , SignorettiA , NakagawaA , ChurchillR , et al. Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews2010, Issue 4. [DOI: 10.1002/14651858.CD006117.pub4] ">Cipriani 2009c</a>; <a href="./references#CD003196-bbs2-0058" title="OmoriIM , WatanabeN , NakagawaA , CiprianiA , BarbuiC , McGuireH , et al. Fluvoxamine versus other anti‐depressive agents for depression. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD006114.pub2] ">Omori 2010</a>; <a href="./references#CD003196-bbs2-0069" title="WatanabeN , OmoriIM , NakagawaA , CiprianiA , BarbuiC , ChurchillR , et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD006528.pub2] ">Watanabe 2011</a>; <a href="./references#CD003196-bbs2-0031" title="CiprianiA , PurgatoM , FurukawaTA , TrespidiC , ImperadoreG , SignorettiA , et al. Citalopram versus other anti‐depressive agents for depression. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD006534.pub2] ">Cipriani 2012</a>), this choice might be questioned. We believe that early drug discontinuation is highly clinically relevant from a clinical point of view because it is one of the most important things the psychiatrist wants to know when starting the prescription of an effective long term treatment. </p> </li> </ul> <ul id="CD003196-lst1-0013"> <li> <p>Our decision to use fixed‐effect meta‐analysis could have introduced a bias in the review process, as there was some visual indication of heterogeneity, although this was rarely statistically significant and so could simply indicate random error. Overall, we believe that the fixed‐effect average is probably the best estimate for guiding clinical practice. The two largest studies (<a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a>) reported conflicting estimates, which contributed to the final heterogeneity (I<sup>2</sup> = 25%). However, this result was robust to the choice of statistical method because no material differences were noted between the random‐effects models and the fixed‐effect models. </p> </li> </ul> <ul id="CD003196-lst1-0014"> <li> <p>The relative risk of serious adverse events or death between valproate and other agents or placebo was not significant; however, included trials were not powered to detect any mortality difference. Because of the low numbers of events, random error is substantial, and estimates of treatment effect are consequently unstable with wide confidence intervals. Systematic reviews of randomised controlled trials may increase statistical power, but absolute numbers of participants who have rare adverse events such as completed or attempted suicide are low (<a href="./references#CD003196-bbs2-0023" title="CiprianiA , BrambillaP , FurukawaT , GeddesJ , GregisM , HotopfM , et al. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD004185] ">Cipriani 2005a</a>), and a few events in one direction or another can completely change the overall outcome (<a href="./references#CD003196-bbs2-0024" title="CiprianiA , BarbuiC , GeddesJR . Suicide, depression, and antidepressants. British Medical Journal2005;330(7488):373‐4. ">Cipriani 2005b</a>). </p> </li> </ul> <ul id="CD003196-lst1-0015"> <li> <p>It is known that Axis I and Axis II psychiatric comorbidity is of clinical interest, especially for bipolar disorder and borderline personality disorder (<a href="./references#CD003196-bbs2-0019" title="BassettD . Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review. Australian &amp; New Zealand Journal of Psychiatry2012;46(4):327‐39. ">Bassett 2012</a>). However, evidence suggests that bipolar disorder and borderline personality disorder are most likely separate disorders and that benefits of mood stabilisers are more predictable in bipolar disorder than in borderline personality disorder (<a href="./references#CD003196-bbs2-0060" title="ParisJ , GundersonJ , WeinbergI . The interface between borderline personality disorder and bipolar spectrum disorders. Comprehensive Psychiatry2007;48:145–54. ">Paris 2007</a>). Therefore, we decided to exclude studies that recruited participants with Axis II comorbidity. Even though our inclusion criteria were aimed at higher internal validity (<a href="./references#CD003196-bbs2-0025" title="CiprianiA , PurgatoM , BarbuiC . Why internal and external validity of experimental studies are relevant for clinical practice?. Epidemiology and Psychiatric Sciences2009;18(2):101‐3. ">Cipriani 2009a</a>), our choice might have limited the external validity of review findings because In clinical practice, patient populations are usually highly heterogeneous. </p> </li> </ul> <ul id="CD003196-lst1-0016"> <li> <p>We found no reports of teratogenic effects, but randomised controlled trials are not intended or designed to evaluate this very important aspect of treatment. Treatment guidelines recommend that valproate should not be routinely used in women of child‐bearing potential in primary or secondary care (<a href="./references#CD003196-bbs2-0041" title="GoodwinGM , Consensus Group of the British Association for Psychopharmacology. Evidence‐based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2009;23(4):346‐88. ">Goodwin 2009</a>). If no effective alternative treatment to valproate can be used, then the patient should be made aware of the risks of taking valproate in pregnancy, and effective contraception should be used (<a href="./references#CD003196-bbs2-0056" title="National Institute of Health and Clinical Excellence (NICE). The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline Number 38. NICE Guidelines2006. ">NICE 2006</a>). </p> </li> </ul> </p> </section> <section id="CD003196-sec2-0015"> <h3 class="title" id="CD003196-sec2-0015">Agreements and disagreements with other studies or reviews</h3> <p>Despite the increasingly widespread use of valproate in bipolar disorder (<a href="./references#CD003196-bbs2-0043" title="HayesJ , PrahP , NazarethI , KingM , WaltersK , PetersenI , et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995‐2009. PLoS One2011;6(12):e28725. ">Hayes 2011</a>), only one systematic review about the long‐term treatment of bipolar disorder has been published in the scientific literature since the first publication of the present review in 2001. The review by Soares and colleagues was published in 2007 and included a total of seven randomised or quasi‐randomised trials that investigated the efficacy of valproate (<a href="./references#CD003196-bbs2-0066" title="Soares‐WeiserK , Bravo VergelY , BeynonS , DunnG , BarbieriM , DuffyS , et al. A systematic review and economic model of the clinical effectiveness and cost‐effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technology Assessment2007;11(39):iii‐iv, ix‐206. ">Soares‐Weiser 2007</a>). Three studies included in <a href="./references#CD003196-bbs2-0066" title="Soares‐WeiserK , Bravo VergelY , BeynonS , DunnG , BarbieriM , DuffyS , et al. A systematic review and economic model of the clinical effectiveness and cost‐effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technology Assessment2007;11(39):iii‐iv, ix‐206. ">Soares‐Weiser 2007</a> were excluded from the present review because we specifically included only randomised trials with a relapse prevention design, which did not recruit acutely ill patients for long‐term treatment. Notwithstanding these differences in inclusion/exclusion criteria, results from these two systematic reviews are consistent overall. Valproate was found to be effective as maintenance therapy for the prevention of relapse in bipolar disorder, but it was possibly more efficacious for the prevention of depressive relapses rather than manic relapses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003196-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram showing study selection process." data-id="CD003196-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram showing study selection process.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003196-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies." data-id="CD003196-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Valproate versus placebo, outcome: 1.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Valproate versus placebo, outcome: 1.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Valproate versus lithium, outcome: 2.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Valproate versus lithium, outcome: 2.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Valproate plus lithium versus valproate alone, outcome: 5.1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Valproate plus lithium versus valproate alone, outcome: 5.1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Valproate versus placebo, Outcome 1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-00101" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Valproate versus placebo, Outcome 1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Valproate versus placebo, Outcome 2 Participant withdrawal from treatment—any cause." data-id="CD003196-fig-00102" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Valproate versus placebo, Outcome 2 Participant withdrawal from treatment—any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Valproate versus placebo, Outcome 3 Participant withdrawal from treatment due to intolerance or non‐compliance." data-id="CD003196-fig-00103" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Valproate versus placebo, Outcome 3 Participant withdrawal from treatment due to intolerance or non‐compliance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Valproate versus placebo, Outcome 4 Adverse events." data-id="CD003196-fig-00104" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Valproate versus placebo, Outcome 4 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-00201" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 2 Number of hospital admissions." data-id="CD003196-fig-00202" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 2 Number of hospital admissions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 3 New drug treatment for mood episode." data-id="CD003196-fig-00203" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 3 New drug treatment for mood episode.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 4 Time to relapse (days)." data-id="CD003196-fig-00204" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 4 Time to relapse (days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 5 Participant withdrawal from treatment—any cause." data-id="CD003196-fig-00205" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 5 Participant withdrawal from treatment—any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 6 Participant withdrawal from treatment due to intolerance or non‐compliance." data-id="CD003196-fig-00206" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 6 Participant withdrawal from treatment due to intolerance or non‐compliance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 7 Adverse events." data-id="CD003196-fig-00207" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 7 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00208"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 8 GAF—number of participants not responding at 24 months." data-id="CD003196-fig-00208" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 8 GAF—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00208">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00209"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 9 Quality of life—number of participants not responding at 24 months." data-id="CD003196-fig-00209" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 9 Quality of life—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00209">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00210"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 10 DSH—number of participants with at least one episode of deliberate self‐harm." data-id="CD003196-fig-00210" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 10 DSH—number of participants with at least one episode of deliberate self‐harm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00210">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00211"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Valproate versus lithium, Outcome 11 Death." data-id="CD003196-fig-00211" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Valproate versus lithium, Outcome 11 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00211">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Valproate versus olanzapine, Outcome 1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-00301" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Valproate versus olanzapine, Outcome 1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Valproate versus olanzapine, Outcome 2 Participant withdrawal from treatment—any cause." data-id="CD003196-fig-00302" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Valproate versus olanzapine, Outcome 2 Participant withdrawal from treatment—any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00303"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Valproate versus olanzapine, Outcome 3 Participant withdrawal from treatment due to intolerance or non‐compliance." data-id="CD003196-fig-00303" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Valproate versus olanzapine, Outcome 3 Participant withdrawal from treatment due to intolerance or non‐compliance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00303">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00401"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-00401" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00401">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00402"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 2 Number of hospital admissions." data-id="CD003196-fig-00402" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 2 Number of hospital admissions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00402">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00403"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 3 New drug treatment for mood episode." data-id="CD003196-fig-00403" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 3 New drug treatment for mood episode. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00403">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00404"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 4 Participant withdrawal from treatment—any cause." data-id="CD003196-fig-00404" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 4 Participant withdrawal from treatment—any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00404">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00405"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 5 Participant withdrawal from treatment due to intolerance or non‐compliance." data-id="CD003196-fig-00405" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 5 Participant withdrawal from treatment due to intolerance or non‐compliance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00405">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00406"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 6 Serious adverse events." data-id="CD003196-fig-00406" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 6 Serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00406">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00407"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 7 GAF—number of participants not responding at 24 months." data-id="CD003196-fig-00407" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 7 GAF—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00407">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00408"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 8 Quality of life—number of participants not responding at 24 months." data-id="CD003196-fig-00408" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 8 Quality of life—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00408">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00409"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 9 DSH—number of participants with at least one episode of deliberate self‐harm." data-id="CD003196-fig-00409" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 9 DSH—number of participants with at least one episode of deliberate self‐harm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00409">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00410"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Valproate plus lithium versus lithium alone, Outcome 10 Death." data-id="CD003196-fig-00410" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Valproate plus lithium versus lithium alone, Outcome 10 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00410">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00501"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 1 Study withdrawal due to episode of mood disorder." data-id="CD003196-fig-00501" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 1 Study withdrawal due to episode of mood disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00501">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00502"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 2 Number of hospital admissions." data-id="CD003196-fig-00502" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 2 Number of hospital admissions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00502">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00503"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 3 New drug treatment for mood episode." data-id="CD003196-fig-00503" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 3 New drug treatment for mood episode. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00503">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00504"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 4 Participant withdrawal from treatment—any cause." data-id="CD003196-fig-00504" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 4 Participant withdrawal from treatment—any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00504">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00505"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 5 Participant withdrawal from treatment due to intolerance or non‐compliance." data-id="CD003196-fig-00505" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 5 Participant withdrawal from treatment due to intolerance or non‐compliance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00505">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00506"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 6 Serious adverse events." data-id="CD003196-fig-00506" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 6 Serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00506">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00507"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 7 GAF—number of participants not responding at 24 months." data-id="CD003196-fig-00507" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 7 GAF—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00507">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00508"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 8 Quality of life—number of participants not responding at 24 months." data-id="CD003196-fig-00508" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 8 Quality of life—number of participants not responding at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00508">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00509"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 9 DSH—number of participants with at least one episode of deliberate self‐harm." data-id="CD003196-fig-00509" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 9 DSH—number of participants with at least one episode of deliberate self‐harm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00509">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003196-fig-00510"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/urn:x-wiley:14651858:media:CD003196:CD003196-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_t/tCD003196-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Valproate plus lithium versus valproate alone, Outcome 10 Death." data-id="CD003196-fig-00510" src="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Valproate plus lithium versus valproate alone, Outcome 10 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-fig-00510">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/media/CDSR/CD003196/image_n/nCD003196-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD003196-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Adverse event</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Valproate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Comparator</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Risk Ratio, Fixed [95% CI]</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b><i>Valproate vs placebo</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acne</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 [0.01, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akathisia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.03, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blurred vision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.13 [0.22, 21.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.17, 6.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 [0.78, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dry mouth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.44 [0.42, 132.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.33 [0.70, 40.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased appetite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 [0.01, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.42 [0.88, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32 [0.94, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polydipsia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.28 [0.49, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polyuria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.38, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sedation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19 [0.86, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sexual dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0006" title="GaoK , VerduinML , KempDE , TolliverBK , GanocySJ , ElhajO , et al. Clinical correlates of patients with rapid‐cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo‐controlled trials. Journal of Clinical Psychiatry2008;69(7):1057‐63. KempDE , GaoK , GanocySJ , ElhajO , BilaliSR , ConroyC , et al. A 6‐month, double‐blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid‐cycling bipolar disorder and co‐occurring substance abuse or dependence. Journal of Clinical Psychiatry2009;70(1):113‐21. [PUBMED: 19192457] ">Kemp 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.17, 6.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tachycardia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 [0.03, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thirst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.32, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tinnitus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.03 [0.80, 45.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b><i>Valproate vs lithium</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akathisia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [0.01, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alopecia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.74 [0.85, 3.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balance problems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.29 [0.22, 23.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive difficulties</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.02, 8.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased appetite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 [0.22, 4.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dry eyes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07 [0.00, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 [0.03, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 [0.10, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haematological dyscrasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 [0.13, 70.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.64 [0.96, 7.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 [0.68, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0002" title="GeddesJR , GoodwinGM , RendellJ , AzorinJM , CiprianiA , OstacherMJ , et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. [PUBMED: 20092882] GeddesJR , RendellJM . Update on the progress of BALANCE. Abstracts of the Sixth International Conference on Bipolar Disorder, 16‐18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders2005;7(Suppl 2):58. GeddesJR , RendellJM , GoodwinGM , for the BALANCE Investigators. BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry2002;1(1):48‐51. RendellJM , JuszczakE , HainsworthJ , van derGuchtE , HealeyC , MorrissR , et al. Developing the BALANCE trial—the role of the pilot study and start‐up phase. Bipolar Disorders2004;6(1):26‐31. ">BALANCE 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40 [0.46, 4.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sore throat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 [0.33, 27.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.02, 8.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stomach pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.33 [0.67, 8.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tachycardia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [0.01, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tremor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a>; <a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.65, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Upper respiratory congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Visual impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.16 [0.01, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0005" title="FindlingRL , McNamaraNK , YoungstromEA , StansbreyR , GraciousBL , ReedMD , et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2005;44(5):409‐17. [PUBMED: 15843762] ">Findling 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 [0.10, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weight gain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003196-bbs2-0003" title="BowdenCL , CalabreseJR , McElroySL , GyulaiL , WassefA , PettyF , et al. A randomised placebo‐controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Archives of General Psychiatry2000;57(5):481‐9. GyulaiL , BowdenCL , CalabreseJR , McElroySL , PettyF , RischSC , et al. Efficacy of divalproex for bipolar depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL. NR464. ">Bowden 2000</a>; <a href="./references#CD003196-bbs2-0004" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. The American Journal of Psychiatry2005;162(11):2152‐61. [PUBMED: 16263857] SheltonMD3rd , RapportDJ , YoungstromEA , ElhajO , BilaliSR , FindlingRL , et al. Is rapid cycling a predictor of nonresponse to lithium?. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York, NY, USA. NR759. ">Calabrese 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 [0.89, 2.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/full#CD003196-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003196-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Valproate versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Study withdrawal due to episode of mood disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.49, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Manic episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.48, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Depressive episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.24, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participant withdrawal from treatment—any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.71, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participant withdrawal from treatment due to intolerance or non‐compliance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Alopecia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [1.15, 5.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Tremor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [1.58, 3.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Weight gain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.04 [1.07, 3.86]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Valproate versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003196-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Valproate versus lithium</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Study withdrawal due to episode of mood disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.87, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Manic episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.90, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Depressive episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.84, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Hypomanic episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.18, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Mixed state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.02, 8.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of hospital admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 New drug treatment for mood episode <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Mania</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Time to relapse (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Participant withdrawal from treatment—any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.77, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Participant withdrawal from treatment due to intolerance or non‐compliance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.49, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.55, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Sedation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.00, 2.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Polyuria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Increased thirst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.15, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [1.16, 3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Enuresis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 GAF—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Quality of life—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 DSH—number of participants with at least one episode of deliberate self‐harm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Valproate versus lithium</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003196-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Valproate versus olanzapine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Study withdrawal due to episode of mood disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Manic only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Depressive only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participant withdrawal from treatment—any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participant withdrawal from treatment due to intolerance or non‐compliance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Valproate versus olanzapine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003196-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Valproate plus lithium versus lithium alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Study withdrawal due to episode of mood disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of hospital admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 New drug treatment for mood episode <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Mania</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Participant withdrawal from treatment—any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Participant withdrawal from treatment due to intolerance or non‐compliance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 GAF—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Quality of life—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 DSH—number of participants with at least one episode of deliberate self‐harm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Valproate plus lithium versus lithium alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003196-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Valproate plus lithium versus valproate alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Study withdrawal due to episode of mood disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of hospital admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 New drug treatment for mood episode <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Any mood episode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Mania</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Participant withdrawal from treatment—any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Participant withdrawal from treatment due to intolerance or non‐compliance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 GAF—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Quality of life—number of participants not responding at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 DSH—number of participants with at least one episode of deliberate self‐harm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Valproate plus lithium versus valproate alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003196.pub2/references#CD003196-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003196.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003196-note-1204">Español</a> </li> <li class="section-language"> <a class="" href="ru#CD003196-note-1203">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003196\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003196\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003196\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003196\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003196\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003196.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003196.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003196.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003196.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003196.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740713982221"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003196.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740713982224"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003196.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d638b4f52937a',t:'MTc0MDcxMzk4Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 